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ABSTRACT  -   EPSTEIN-BARR VIRUS ENCODED DECONJUGASES 
 
 
 
The post-translational conjugation or deconjugation of proteins by ubiquitin (Ub) or ubiquitin-
like molecules (UbLs: e.g. SUMO, NEDD8, ISG15) has emerged as a major regulatory 
mechanism of various cellular activities. Viruses have developed mechanisms to exploit those 
pathways for their own benefit. RNA and DNA viruses express their own E3 ligases or 
manipulate cellular E3 ligases. Also several viral encoded DUBs or ULPs have been described, 
e.g. facilitating the suppression of ubiquitination and ISGylation mediated antiviral effects. 
Epstein-Barr virus (EBV) is a large double-stranded DNA tumor virus encoding 100 open 
reading frames (ORFs). EBV is associated with a variety of malignancies of lymphoid cells, like 
Burkitt´s lymphoma and Hodgkin´s lymphoma as also of epithelial cells, like nasopharyngeal 
carcinoma and gastric carcinoma.  
The overall aim of this study was to identify and functional characterize EBV encoded 
deconjugases. We screened an EBV-ORFeome library for their activity against Ub-, NEDD8-, 
SUMO-1,-2,-3 and ISG15-GFP reporter. As a result we discovered that the BSLF1- and BXLF1-
ORF comprised deubiquitinating activity. We could also detect that the large tegumental protein 
BPLF1-N cleaves the NEDD8-GFP reporter with similar efficiency as the Ub-GFP reporter. 
Following this observation we could show that BPLF1-N was able to process Ub- and NEDD8-
linked functional probes with similar efficiency suggesting equal affinities towards ubiquitinated 
and neddylated substrates. We could show that BPLF1-N binds to and deneddylates cullins, 
which are assembled in cullin-RING ligases (CRLs). This CRL deneddylation facilitated the 
stabilization of their substrates involved in cell cycle regulation. Those accumulated BPLF1-N 
controlled CRL substrates were essential for an S-phase like cellular environment and 
endoreduplication in BPLF1-N expressing cells. We further demonstrated that the impact of 
BPLF1-N expression on viral genome replication was dependent on stabilization of the DNA 
licensing factor CDT1. 
 
 
 
 
 
 
 
 
ABSTRACT  -   AMOTL2 IN CONTROL OF CELL TOPOLOGY 
 
 
 
During developmental morphogenesis, cells migrate, differentiate and organize into multicellular 
structures. As a distinct step in organ formation, epithelial cells join together via cell-cell 
junctions to form sheets of cells that separate cellular compartments from each other. 
Endogenous forces, generated by contractile actin, are transmitted over cell-layers in part by the 
connection to adhesion junctions and E-cadherin. These forces affect cellular geometry (cell size 
and shape) and topology (connectivity among cells in a tissue). Exactly how E-cadherin connects 
to the actomyosin network has been less clear.  
The Angiomotin protein family of scaffold proteins comprises three members Amot, AmotL1 and 
AmotL2, were each is expressed as two isoforms in mammalians. These proteins act as scaffolds 
in that they contain interaction sites enabling the formation of protein complexes. 
In our work, we show that AmotL2 p100 binds to the adherens junction components E-cadherin 
and MAGI1 and associates to contractile actin fibers which connect cells over multiple layers. 
Silencing of AmotL2 in epithelial cells in vitro and in zebrafish keratinocytes in vivo resulted in 
loss of actin filaments perpendicular to cellular junctions and dramatic changes in cellular 
geometry. As a consequence, the packing of epithelial cells in the typical hexagonal patterns was 
severely perturbed and the ability to form 3-D structures was lost. Cells depleted of AmotL2 also 
showed increased fluidity and elasticity when subjected to mechanical force. We propose that 
AmotL2 is a critical component in the adhesion junctions that controls intracellular contractility 
as well as relaying forces between cells. 
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1.1  INTRODUCTION  -  EPSTEIN-BARR VIRUS ENCODED DECONJUGASES 
 
 
1.1.1  The ubiquitin and ubiquitin-like modification system 
 
The post-translational modification of proteins by Ub (ubiquitin) or UbLs (ubiquitin-like 
molecules: e.g. SUMO, NEDD8, ISG15) has emerged as a major regulatory mechanism of 
various cellular activities. Those controlled processes include protein transcription, 
translation, trafficking and degradation, signal transduction, replication and apoptosis (1, 2, 3, 
4, 5). So far 13 UbLs are described in human. All of them have a size between 8-18 kDa and 
they all show a high secondary structure homology to ubiquitin (2).  
Conjugation of Ub and UbLs to their targets requires the sequential action of three enzymes: a 
modifier-activating enzyme (E1), one of several modifier conjugating enzymes (E2s), and one 
member of a large and diverse group of modifier-target ligases (E3s) that mainly determines 
target specificity (1). This enzyme cascade mediates the conjugation of the C-terminal glycine 
of Ub or UbL to the epsilon-NH2 group of a lysine residue (K) of the target protein. Ub and 
UbLs are produced as precursor proteins (Ub also as a polypeptide), and carboxy-terminal 
processing by specific proteases is required to generate an active modifier. Those specific 
deconjugating enzymes, called DUBs (deubiquitinating enzymes) and ULPs (Ubl-specific 
proteases), also cleave the modifier from its target protein by hydrolyzing the covalent 
bondage between substrate and modifier. The purpose of this reaction is to establish a 
sufficient pool of free Ub/Ubls and to determine certain signaling or functional alteration 
caused by the modification (6).  
An overview of the ubiquitin and ubiquitin-like modification system with examples for the 
non-proteolytic and proteolytic outcomes are visualized in figure 1. 
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Figure 1. Ub polypeptides or UbL pro-peptides need to be processed from DUBs or ULPs to make their terminal 
Glycin accessible for conjugation. Via an enzymatic cascade of activating enzyme (E1), conjugating enzyme 
(E2) and substrate ligase (E3) the modifier gets covalently linked to its substrate. This modification can either 
have a non-proteolytic or a proteolytic outcome. After signaling the modifier gets deconjugated from its 
substrate by DUBs or ULPs for possible recycling into the system.  
 
 
 
1.1.2  Ubiquitin modification 
 
Ubiquitin, a small globular protein composed of 76 amino acids, is highly conserved during 
evolution. The first discovered function of ubiquitin is its involvement in the UPS (ubiquitin-
proteasome system). This pathway is a major intracellular system for protein degradation. The 
connection of at least four K48 linked Ub molecules to a protein serves as localization signal 
to the proteasome where the labeled protein gets degraded (1). This pathway plays a crucial 
role in a wide variety of cellular function, including degradation of damaged or unneeded 
proteins, cellular trafficking, antigen processing, cell cycle regulation and apoptosis (7).  
Apart from the described K48 Ub chain mediated protein degradation several other Ub 
mediated function have been described. Ubiquitin contains seven lysine residues K6, K11,  
K27, K29, K33, K48, and K63. Formation of the ubiquitin chain can occur by linking the 
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 ubiquitin polymer to any of these lysine residues in homogeneous or mixed form. The length 
and the linkage construction of the created Ub chain determine the faith of the modified 
protein. Apart from modification via K48 Ub chains, monoubiquitination and K63 Ub chain 
conjugation are the best characterised Ub modifications. Many membrane receptors are 
monoubiquitinated, which serves in most cases as endocytosis signal and in many 
circumstances as signal for lysosomal degradation. Also histones are monoubiquitinated, 
which serves as signal for histone-mediated transcriptional regulation. Monoubiquitination 
has also been described to alter sub-cellular location or determine cellular interaction of the 
modified substrate (8, 9).  
For instance PCNA (proliferating cell nuclear antigen) is a homotrimeric replication sliding 
clamp that encircles DNA and provides a platform to recruit other proteins involved in DNA 
replication and repair. Monoubiquitinated PCNA recruits TLS (translation synthesis) 
polymerases, which display low processivity and reduced fidelity allowing DNA lesion 
bypass, to replace the high-fidelity polymerases. The monoubiquitination of PCNA can be 
further extended to K63-linked polyubiquitin chains. This polyubiquitination activates an 
alternative lesion bypass pathway called template switch, which recruits the undamaged 
strand of the DNA duplex as a template to direct DNA synthesis (10).  
Further described protein-protein interactions mediated via K63-linked polyubiquitination are 
important for kinase signalling activation (e.g. leading to NF-κB activation), receptor 
endocytosis and protein trafficking (11). The best characterized UbL- modifier in human are 
SUMO, NEDD8 and ISG15.  
 
 
1.1.3  SUMO modification 
 
The mammalian SUMO (Small ubiquitin-like modifier) family is comprised of three members 
with described physiological function. SUMOs have a size of about 95 amino acids and 
constitute a highly conserved protein family found in all eukaryotes. SUMO-1 share 50% 
sequence identity with SUMO-2 and -3. SUMO-2 and SUMO-3 share 95% sequence 
identity. SUMO-2 and -3 are able to form monomeric and heteromeric poly-SUMO chains 
like Ubiquitin. SUMO-1 in contrast, is not able to form poly-SUMO chains but may bind 
covalently to SUMO-2 and -3 conjugated chains and terminate them. Most SUMO-modified 
proteins, which have been characterized in human, are involved in transcription. The 
transcriptional effects of SUMO can be divided into two groups, those that involve PML 
4 
 
 
 
 
nuclear bodies and those that involve sumoylated transcription factors bound to DNA 
promoters (12).  
PML nuclear bodies are matrix-associated domains that recruit an ever-growing variety of 
proteins.  The PML-protein is the key organizer of these domains, which up on sumoylation 
facilitates the formation of PML nuclear bodies, recruiting among others transcription factors, 
which get activated via this association. Sumoylation occurring direct on the transcription 
factor facilitates in most cases transcriptional repression. This occurs either by altering the 
stability of a DNA bound transcription factor or by the recruitment of a transcriptional 
repressor. In general most sumoylated substrates are localized in the nucleus and many of 
those substrates require their NLS (nuclear localization sequence) for sumoylation (12).  
The most abundant SUMO-1 conjugate in vertebrate cells is RanGAP1. This protein is the 
GTPase activating protein for the small GTPase Ran, which plays a central role in nuclear 
transport. SUMO-1 modification of RanGAP1 facilitates binding of the modified protein to 
the nuclear pore complex. This tightly bound RanGAP1 was shown to be crucial in nuclear 
import assays in vitro and soluble RanGAP1 could not substitute for it. One way SUMO 
affects the function of its substrates is sumoylation on otherwise ubiquitination specific lysine 
residues. PCNA or IB are examples for this phenomena. In the case of PCNA sumoylation 
and ubiquitination compete for the same site whereas sumoylation was shown to alter PCNAs 
function by inhibiting ubiquitination dependent post-replication DNA repair. Also the 
sumoylation of ubiquitination sites of particular high molecular weight proteins after various 
cellular stress conditions with SUMO-2 and-3 chains was reported. This sumoylation pattern 
was reversed after normalization of the cellular stress stimuli, suggesting a role of 
sumoylation to inhibit those sites for ubiquitination mediated proteasomal degradation (12).  
 
 
1.1.4  NEDD8 modification 
 
The UbL-modifier NEDD8 (Neuronal-precursor cell-expressed developmentally down-
regulated protein 8) was originally discovered as a down regulated protein in neural precursor 
cells during the development of murine brain. The 76 amino acid big modifier is very similar 
to Ubiquitin in size, structure and charge distribution. Both modifiers share an almost 60% 
sequence identity. The most prominent neddylated substrates are the cullin family, which 
comprise in human six members (Cul-1,-2,-3,-4a,-4b,-5). Cullins serve as scaffold/bridge 
proteins in multi subunit ubiquitin ligase complexes also called CRLs (cullin-RING ligases). 
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The C-terminus of a cullin integrated in such a complex serves as binding site for Roc1 
orRoc2, which are E2 binding adaptors. Roc1 or Roc2 attract and bind an E2 conjugating 
enzyme, which brings ubiquitin to the complex required for CRL-substrate ubiquitination. 
The N- terminus of a CRL integrated cullin serves in most cases as binding site for a variable 
adaptor protein. On this adaptor protein (or direct to the cullin N-terminus) binds a substrate-
targeting module, which determines the pool of substrates connecting to the specific CRLs. 
Via the different composition of mainly those substrate recognition modules, 400 different 
CRLs have been described in human. It is believed, that 20% of all proteins targeted for 
proteasomal degradation are polyubiquitinated by CRLs. The C-terminal neddylation of 
cullins assembled in CRLs was shown to enable a sufficient polyubiquitination of the CRL 
substrate protein (13, 14).  
Also other neddylated substrates have been described. The E3 ligase MDM2, which 
ubiquitinates p53, may also neddylate p53, which inhibits its transcriptional activity (15).  
The VHL (von Hippel–Lindau) tumour suppressor protein is the cause of the familial VHL 
disease (cancer syndrome) and
 
most sporadic RCC (renal clear-cell) carcinomas. Needylation 
of VHL has been reported to be important for VHL binding to fibronectin and to promote its 
matrix assembly. A non-neddylateable
 
VHL mutant failed to bind to and promote the 
assembly of fibronectin. Deregulated ECM, as well as abnormal cell-matrix interactions
 
are 
hallmarks of solid tumors. Alterations in the fibronectin component of the ECM have been 
correlated with cellular transformation, like VHL-associated tumorigenesis (16).  
Also BCA3  (breast cancer associated protein 3) was shown to be a NEDD8 substrate and to 
function as a tumor suppressor upon modification. When NEDD8 is removed from BCA3, 
oncogenes are no longer suppressed, resulting in resistance to apoptosis and excessive cell 
proliferation. Neddylation of BCA3 suppresses NFκB-dependent transcription through its 
ability to bind to p65 and the cyclin D1 promoter (17).  
The EGFR (epidermal growth factor receptor) functions as a tyrosine kinase upon activation 
by its ligands, which triggers DNA synthesis and cell proliferation. It was shown, that EGFR 
neddylation enhances its subsequent ubiquitination, resulting in its endocytosis and sorting for 
lysosomal degradation (18). 
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1.1.5  ISG15 modification 
 
Human ISG15 (IFN-stimulated gene 15) has a size of 157 amino acids and consist of two 
domains, where each domain is structurally similar to ubiquitin. ISG15, like other ISGs, is an 
interferon-inducible gene product, which is strongly upregulated upon viral or bacterial 
infection. It was further described to be upregulated after LPS (Lipopolysaccharide) and 
double stranded RNA stimuli. The first discovered substrate of this modifier was Spi2a (serin 
protease inhibitor 2a), which regulates intracellular proteases in antigen-presenting cells. In 
general ISG15 is considered as a broad-spectrum inhibitor of virus production upon viral 
infection. Antiviral activity associated with viral or host protein ISGylation has been reported 
for DNA and RNA viruses, like HCMV (human cytomegalovirus), HSV (herpes simplex 
virus), SV (Sindbis virus) and HCV (hepatitis C virus). Mass spectrometric analysis has led to 
the identification of at least 200 putative ISG15 target proteins. Many of them have crucial 
functions in the type I IFN response, including JAK1 and STAT1. ISGylation of those 
signalling proteins was shown to increase their activity to enhance the cellular response to 
interferons (19). This was achieved by e.g. induction of the antiviral effector enzymes PKR 
and RNase L. Those protein activations trigger a global inhibition of protein synthesis and 
virus replication. This is achieved through the phosphorylation of eIF-2α (for PKR) and 
breakdown of RNA (for RNase L). It was also shown that up on activation of PKR and RNase 
L an upregulation of ISG15 mRNA levels was achieved (20, 21).  
Upon viral infection, ISG induction occurs in two intervals: first an IFN-independent 
induction of a subset of ISGs is induced and second an IFN-dependent induction via the 
production of IFN-α/β follows. In many viral infections, IFN-independent ISG induction is 
mediated by IRF-3 phosphorylation, homodimerization, and nuclear translocation. Activated 
IRF3, in turn, induces the expression of type I IFN genes, whose products trigger strong 
induction of a subsets of ISGs, including IFN-β which after its release and ligand-binding to 
its receptor initiates IFN-dependent ISG induction via the IFN receptor and JAK/STAT 
signalling pathways. ISG15 has been reported in HBV (hepatitis B virus) to prevent virus-
mediated degradation of IRF3 (interferon regulatory factor 3), thereby increasing the 
induction of IFNβ expression (22).  
ISG15 can also be secreted from stimulated cells by a yet not described mechanism and is 
believed to function as a cytokine to modulate the immune response. In this manner ISG15 
was shown to stimulate interferon γ secretion by monocytes and macrophages, proliferation of 
natural killer cells, and chemotactic responses in neutrophils (23).  
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Some viruses have developed specific strategies to counteract the activity of ISGs. The 
influenza B virus protein NS1B is able to bind to ISG15 and by doing so inhibits protein 
ISGylation (24).  
ISG15 overexpression in cell culture was shown to hinder efficient budding of Ebola VP40 
virus like particles. The Ebola virus matrix protein VP40 is a major viral structural protein 
and plays a central role in virus assembly and budding at the plasma membrane of infected 
cells. VP40 needs to be ubiquitinated to facilitate efficient viral budding. It has been reported, 
that the cellular E3 ligase Nedd4, which ubiquitinates VP40, gets ISGylated, which inhibits its 
enzymatic activity hindering efficient Ebola VP40 virus like particle budding (25).  
 
 
1.1.6  Human DUBs and ULPs and examples of their function 
 
All DUBs and ULPs are Cystein proteases, with the exception of the JAMM 
metalloproteases, which cleave the modifier from the substrates in a Zn
2+
- and ATP-
dependent manner. So far approx. 100 human DUBs have been identified, and based on the 
sequence similarities, they have been classified into five distinct subfamilies: USPs 
(Ubiquitin-specific proteases), UCHLs (Ubiquitin carboxyl-terminal hydrolases), OTUs 
(Otubain proteases), MJDs (Machado-Joseph disease proteases) and JAMMs 
(Jab1/MPN domain metalloenzymes) (6). The human ULPs are represented by the SENP 
(sentrin specific peptidase) family (12). 
 
 
1.1.7  USPs 
 
USPs (Ubiquitin-specific proteases) belong to the largest and most diverse DUB family. 
Those enzymes have specific substrates and can regulate distinct signaling pathways at 
various levels. Examples include USP7, which stabilizes p53 and MDM2 (E3 ligase of p53) 
in cells (26). CYLD is a K63-linked Ub chain speciﬁc USP in the NF-κB pathway that 
inhibits the activation of the IKK kinase complex (27). USP28 stabilizes the transcription 
factor c-myc (28), while USP8/UBPY affects endosomal trafficking (29). USP14 is associated 
with the proteasome and is required for ubiquitin recycling by removing K48-linked Ub 
chains from proteasomal substrates (30).  
Beside the main characteristic of USPs, to cleave ubiquitin linkages, members of this family 
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have also been described to have dual activities towards UbL-modifier. For example USP2, 
USP5 and USP14 are able to hydrolyze ISG15 conjugates. Those activities were previously 
elucidated by the ability of those USPs to bind to the suicidal probe ISG15-VS (31). Those 
chemical probes are widely used to characterize catalytic active cysteine deconjugases. Those 
probes contain besides Ub or a specific UbL a reactive compound, which binds and inhibits in 
most cases the catalytic site of the targeted enzyme (32).  
Several USPs have been described to comprise a dual specificity to Ub and NEDD8 (33). For 
instance USP21 has been described to recognize NEDD8 and to be able to deneddylate 
cellular substrates (34). Several USPs have been implicated in malignant transformation 
including for example the product of the cylindromatosis or turban tumor syndrome gene 
CYLD, which was identified as a regulator of the NF-kB pathway (2). Some USPs exert 
distinct growth regulatory activities by acting as oncoproteins or tumor suppressor proteins 
(3).  
The size of USPs ranges between 330 and 3500 amino acids and their catalytic domain 
comprising conserved cysteine and histidine boxes has a size between 300 and 850 amino 
acids. The N- and C-terminal extension domains of USPs determine their substrate specificity 
and are involved in protein-protein interaction and determination of cellular localization (35). 
Structural studies have deﬁned the USP domain fold, and 5 crystal structures of mammalian 
USP domains have been published (36-40). USP domains share a common fold, which is 
conserved in almost all USPs. This structure was defined from the crystal structure of USP7. 
This USP domain resembles a three-domain architecture comparable to an open hand 
formation containing Thumb, Palm and Fingers. The Thumb consists of eight α helices, while 
the Palm contains eight central β strands and two helices. The fingers are comprised of four β 
strands in the center and two at the tip. The catalytic triad residues are located between the 
Thumb (Cys) and Palm subdomains (His/Asp) (37).  
 
 
1.1.8  UCHLs  
 
The UCHL (Ubiquitin carboxyl-terminal hydrolase) family is comprised of 4 members 
(UCHL1, UCHL3, UCHL37 and Bab1), which have generally small sizes (20-30 kDa). Their 
sequences are conserved among species with approximately 40% homology. UCHL1 is 
highly expressed in neurons and reduced levels have been observed in various 
neurodegenerative diseases. Mutations in the UCHL1 gene have been reported to be linked to 
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Parkinson’s disease and expression of UCHL1 was shown to rescue synaptic dysfunction in 
Alzheimer’s disease model mice (41, 42). Abnormal overexpression of UCHL1 has been 
reported to relate to several forms of cancer (43). UCHL3 is expressed in various tissues and 
cleaves beside Ub also neddylated substrates. Studies using UCHL3 deficient mice have 
suggested a role in growth and cell
 
survival (44, 45). UCHL37 specifically cleaves K48-
linked Ub chains and is associated with the 19S regulatory subunit of the 26S proteasome 
(46).  
 
 
1.1.9  OTUs 
 
OTUs (Otubain proteases) are a recently identified DUB family with so far approximately 15 
members. They belong to the ovarian tumor superfamily of proteins with more then 100 
members. OTU homologues in different species show a high degree of homology. Also their 
enzymatic cores are highly conserved but their substrate specificities appear to be quite 
diverse. Otu1 (otubain 1) has been shown in vitro to cleave K48-linked Ub chains and to 
decrease global Ub conjugate level after overexpression in vivo (47), (48). Otu2 (otubain 2) 
was shown to be inactive in vitro against ubiquitin peptide/isopeptide-linked substrates (49), 
but was able to cleave the flurogenic probe Ub-AMC (50).  
Other human OTU proteins known to have DUB activity are A20, Cezanne, TRABID, DUBA 
and VCIP135. A20 is a dual active enzyme comprising DUB and E3 ligase
 
activities, which 
are required for termination of TLR (Toll-like receptor) signalling resulting in NF- B 
activation and inactivation
 
of TNF (tumour necrosis factor) induced cytotoxicity and 
apoptosis (51, 52). Similar to A20, Cezanne has been shown to inhibit NF-κB through 
modulation of the ubiquitination state of two of its positive regulators, TRAF6 and RIP-1 (53, 
54). Cezanne was shown accumulate in acute lymphoblastic leukemia and Burkitt lymphoma 
(55). While the precise role of Cezanne in cancer is unknown, its inhibition of NF-κB 
suggests that Cezanne may act as a tumor suppressor. VCIP135´s DUB function was 
described to be required for Golgi membrane fusion (56) and DUBA1 was reported to 
deubiquitinate the E3 ligase TRAF3 resulting in negative regulation of IFN-1 signalling and 
down regulation of the innate immune response (57). 
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1.1.10  MJDs 
 
MJDs (Machado-Joseph disease proteases) are conserved cysteine proteases that include four 
human DUBs (Ataxin-3, ATXN3L, Josephin-1 and Josephin-2). MJDs are conserved 
throughout eukaryotes and share a common cysteine protease domain (Josephin domain) of 
approximately 180 amino acids. The first discovered and best characterized MJD is Ataxin-3. 
Insertion of a polyglutamine repeat in Ataxin-3 was shown to cause the neurodegenerative 
Machado-Joseph disease giving this DUB class its name. In contrast to ataxin-3, much less is 
known about the other three human MJDs (58).  NMR and crystallization based structural 
analysis has been published for Ataxin-3 but for no other MJDs (59). ATXN3L, Josephin-1 
and -2 have been shown to possess DUB activity but no substrates are described so far (58). 
 
 
1.1.11  JAMMs 
 
JAMMs (Jab1/MPN domain metalloenzymes) comprise 5 members with described DUB 
activity. With a big exception to all other DUBs, JAMMs are lacking a catalytic cysteine. 
Instead, they are metalloproteases, which coordinate a catalytically essential zinc ion within 
their active sites. The three best known JAMMs are Poh1, Jab1 and Brcc36. Poh1 is a subunit 
of the 19 S subcomplex which releases K48-linked polyUb chains from substrates targeted to 
the proteasome for degradation. It has been suggested that Poh1 functions as a proteasomal 
“proofreading” device that determines the fate of incoming substrates as to whether they will 
be rescued or degraded (60).  Jab1 is a component of the CSN (COP9 signalosome), a 
multisubunit complex very similar to the 19S proteasome lid complex, which cleaves NEDD8 
of the cullins assembled in CRLs (61). Brcc36 was shown to recognize and cleave particular 
K63-linked ubiquitin chains. Among others Brcc36 is a component of the BRCA1-A 
complex, which specifically recognizes K63-linked ubiquitinated histones H2A and H2AX at 
DNA lesions sites, leading to target the BRCA1-BARD1 heterodimer to sites of DNA damage 
at double-strand breaks (62).  
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1.1.12  ULPs 
 
Human ULPs (Ubl-specific proteases) comprised the SENP (sentrin specific peptidase) 
family, which consist of eight members. They are all homologues of the earlier discovered 
yeast ULP1 homologue. ULP1 and SENPs are classified as a large group of cysteine 
proteases, which catalyze cleavage of the peptide bond after the C-terminal glycine to activate 
the modifier as well as deconjugate them from their substrate. ULP1 and SENPs are 
comprised of a 200 amino acid long catalytic domain containing the active residue triad Cys, 
His and Asp. Their N- terminal domain has a variable length and sequence and is responsible 
for localisation, target interaction and specificity. One member, SENP8, also called NEDP1 or 
DEN1, is specific for NEDD8 activation and substrate deconjugation. SENPs have been 
shown to have distinct sub-cellular localizations controlled by their non-conserved N-terminal 
regions.  SENP1 and SENP3 are predominantly localized into the nucleus. SENP2 isoforms 
are found in the cytoplasm, binding to the nucleoplasmic side of the nuclear pore complex ore 
localize to PML nuclear bodies. SENP6 is localized in the cytoplasm (12). 
 
 
1.1.13  Human virus encoded DUBs and their described function 
 
Nairoviruses and Arteriviruses, two unrelated RNA virus families, have been shown to 
express OTU domain-containing proteases. The L-protein of Nairoviruses, e.g. from the 
highly pathogenic CCHFV (Crimean-Congo Haemorrhagic Fever Virus) has been shown to 
process Ub and ISG15 conjugates and pro-ISG15 and pro-NEDD8 in vitro. CCHFV was also 
able to cleave Ub and ISG15 conjugates in cells. ISGylation and ubiquitination mediate 
antiviral effects. The NF-κB immune pathway is regulated by ubiquitination. CCHFV-L was 
described to inhibit NF-κB activation by the inhibition of endogenous p65 nuclear 
translocation upon TNFα stimulation (63).  
The SARS corona virus encoded PLpro protein was described to show deubiqitinase and 
isgylase activity in vitro. It is an enzyme with dual function first described to carry out N-
terminal processing of the viral replicase polyprotein and then later also to cleave K48-linked 
polyubiquitin chains and ISG15 pro-peptides in vitro. Crystallization of PLpro revealed that it 
belongs to the USP family but its function as a DUB in the course of infection has not been 
demonstrated (64). Also the human corona virus NL63 was reported to encode the PLP2 
protein, an enzyme with dual function. PLP2 was also first described to be involved in viral 
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replicase polyprotein processing and later on found to posses DUB activity. PLP2 was able to 
cleave K48-linked Ub chains and bind to the Ub-VS suicidal probe in vitro (65).  
Also the adenovirus encoded protease adenain has been described as an enzyme with dual 
function. Adenain is a nuclear and cytosolic protein. It was first described to be involved in 
virion maturation by cleaving e.g. viral capsid precursor and to be involved in cell lysis and 
release of the virions by cleaving cytoskeletal proteins (66). Adenain was described to cleave 
K48-linked Ub chains and ISG15 pro-peptides in vitro. During adenoviral infection the 
overall levels of ubiquitinated proteins (especially in the nucleus) decreased with increased 
adenain expression levels. The involvement of the adenain comprised DUB activity in the 
viral life cycle is not elucidated and no substrates are described yet (67).  
The HHV (human herpesvirus) family comprises eight members, which are subcategorized in 
-, - and - herpesviruses according to their site of latency. All human herpesviruses encode 
for a large tegumental protein. The N-termini of all of these proteins have been shown to 
contain a conserved region with comprised DUB activity (68). The first discovered member 
was UL36 of HSV1, which was detected by usage of the suicidal probe Ub-VME in HSV-1 
infected cell lysates. The crystal structure of a mouse herpesvirus homologue, MCMV 
(murine cytomegalovirus) suggests that the herpesviral DUBs represent a new family of 
deubiquitinating enzymes, which is called “herpesvirus tegument USPs”(69).  
Among the best characterized UL36 homologues in human herpes viruses are BPLF1 from 
Epstein-Barr virus, UL48 from human cytomegalovirus and ORF64 from Karposi Sarcoma 
virus. UL36 was shown in further investigation to cleave K48-linked Ub-chains in vitro (69). 
In earlier work a null mutant was generated in the UL36 gene to elucidate its role in the virus 
life cycle. Absence of UL36 lead to failure in targeting capsids to the correct maturation 
pathway resulting in accumulation of DNA-filled capsids in the cytosol not maturing into 
enveloped viruses (70). It remains unclear if this detected phenotype is due to elimination of 
UL36´s DUB activity because the UL36 null mutation, containing an internal deletion of 
amino acid 362-1555, does not eliminate the active site residues but may interfere with 
folding and enzymatic activity. Also UL48 was shown to bind to the DUB probe Ub-VME 
and cleave K48-linked Ub-chains in vitro as described for UL36. Its catalytic active Cys- and 
His- residues were characterized via mutation analysis (71). Orf64 from KSHV was shown to 
be capable of deubiquitinating cellular proteins in vitro and in vivo. Orf64´s DUB activity was 
detectable against K48- and K63-linked Ub chains in vitro. Also the catalytic active cysteine 
was characterized via mutation analysis. Cell fractionation studies revealed that Orf64 is 
localized in the cytosol and nucleus. To test the function of ORF64, siRNA (short interfering 
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RNA) knockdown studies on latently infected cell, which were induced into lytic replication, 
were conducted. The depletion of Orf64 by siRNA resulted in decreased lytic viral 
transcription and decreased lytic protein expression (72).  
 
 
1.1.14  The role of  Ubiquitin and UbL-modifiers in the life cycle of human viruses 
 
Given the central role of Ub- and UbL-modifications it is not surprising that many pathogens 
have devoted a considerable part of their genetic information to the production of proteins that 
mimic, block or redirect the activities of their host conjugating/deconjugating machineries. 
Modulation of those pathways is involved in virtually every step of the virus life cycle 
including virus entry, replication and assembly of new virus particles, immunity avoidance 
and virus exit. 
 
 
1.1.15  Viral entry 
 
Viral entry can be broadly defined as all events, leading to the arrival of the uncoated virus 
genome into the nucleus. HSV (Herpes simplex virus) entry into cells is a multistep process 
that engages the host cell machinery. In experiments, were the proteasome was blocked by 
usage of proteasomeal inhibitors, viral entry was disabled at an early step, after capsid 
penetration into the cytosol but prior to capsid arrival at the nuclear periphery. In addition, 
HSV successfully entered cells in the absence of a functional host ubiquitin-activating 
enzyme, suggesting that viral entry is ubiquitin independent. It was proposed, that 
proteasomal degradation of virion and/or host proteins is required for efficient delivery of 
incoming HSV capsids to the nucleus. The candidate proteins remain to be elucidated (73). 
 
 
1.1.16  Viral replication 
 
In the case of host replication interference, generally DNA tumor viruses modulate the cell 
cycle to enhance their own replication. A common mechanism shared by these viruses, is to 
target cell cycle regulator proteins for degradation, which often results in cell transformation. 
A classical example is the viral mediated down regulation of the tumor suppressor p53. The 
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HPV (human papillomavirus) -16 and -18, E6 proteins redirect the cellular single protein E3 
ligase E6AP to mediate proteasomal degradation of p53, which contributes to their 
oncogenicity by allowing uncontrolled cellular proliferation without induced apoptosis (74). 
A more common mechanism to control the turn over of particular cellular proteins is the 
manipulation of CRLs (cullin-RING-ligases). Examples for viral targeting of CRLs are the 
HPV-16 and -18, E7 proteins, which function as a substrate-binding module in a cullin 2 
based CRL. This assembled complex targets the Retinoblastoma protein (pRb), a tumor 
suppressor controlling G1-S-phase transition, for proteasomal degradation, shutting of this 
cell cycle arrest point (75).  
The Adenovirus proteins E1B55K and E4orf6 form a dimer, which functions as a substrate 
binding module in a cullin 5 based CRL, targeting the tumor suppressor p53 and the MRN- 
(Mre11, Rad50, Nbs1) complex, which is involve in DNA double strand break repair, for 
proteasomal degradation (76). E1B55K also contains a consensus site for sumoylation 
responsible for its nuclear localization. A sumoylation site mutant (K104R) showed altered 
localization and reduced ability to bind to p53, which also resulted in reduced cell 
transformation rates (77).  
The adenovirus E4orf4 and the HPV encoded E2 proteins were shown to inhibit the cell cycle 
by interfering with the APC (anaphase-promoting complex). APC is a cellular E3 ubiquitin 
ligase, which is essential for progression through the M-phase. Both viral proteins were 
additional described to inhibit the degradation of cyclin B resulting in a G2/M phase arrest 
(78).  
SV40 (Simian-Virus 40) expresses its LT (large T antigen), which binds to the SCF (Skp1, 
Cullin1, F-box)-complex (cullin1 based CRL) by inhibiting the substrate binding module F-
box protein Fbw7. Most of the Fbw7 targeted substrates are potential cell cycle regulator or 
oncogenes like cyclin E, c-Myc, c-Jun and Notch, which up on inhibition of Fbw7 get 
stabilized (79).  
The HPV encoded E2 protein and the adenovirus E4orf4 were shown to inhibit the cell cycle 
by interfering with the APC. Both viral proteins were additional shown to inhibit the 
degradation of cyclin B resulting to a G2/M phase arrest (80).  
Cytidine is a component of RNA, which is formed when cytosine is attached to a ribose ring. 
After infection of RNA retroviruses, host cells are trying to diminish cytidine to disturb viral 
replication. The cellular APOBEC- (apolipoprotein B mRNA editing enzyme catalytic 
polypeptide-like) family are mRNA editing enzymes, which edit cytosine to uracil essential 
for RNA synthesis. It has been shown that APOBEC3G was able to diminish the non-coding 
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strand of the HIV genome by converting deoxycytosin to deoxyuracil resulting in guanin to 
adenin hypermutations in the viral coding strand, restricting its propagation. To prohibit this 
pathway HIV encodes for the Vif protein, which functions as a substrate-targeting module in 
two described Cul5 based CRLs that target APOBEC3G for polyubiquitination and 
proteasomal degradation (81, 82).  
Instead of hijacking cellular E3 ubiquitin ligases several viruses have been described to 
encode their own E3 ubiquitin ligases within their genome. HSV-1 encodes for the ICP0 
(infected cell protein 0), an E3 ubiquitin ligase, which has been shown to induce 
polyubiquitination and degradation of a variety of proteins, including the PML protein, G1/S-
phase specific cyclin D3, p53 and the DUB USP7. ICP0 contains two E3 ligase sites. One of 
those sites recruits the cellular E2 ubiquitin conjugating enzyme UbcH5a as well as the DUB 
USP7. ICP0 has also been shown to undergo autoubiquitination, which was reversed by the 
recruited USP7. ICP0 was also shown to facilitate polyubiquitination and proteasomal 
degradation of USP4. When cells were infected with an ICP0 null mutant an enhanced viral 
replication was detected. Among all known targeted proteins of ICP0, the polyubiquitination 
and degradation of PML was suggested for the detected replication phenotype (83).  
Also KSHV (Kaposi sarcoma herpesvirus) was shown to encode a protein with E3 ubiquitin 
ligase function, called RTA (replication and transcription activator). RTA was earlier 
described to serves as transactivator protein, which is essential for activation of viral DNA 
replication upon initial infection and reactivation from latency. This viral multifunctional 
protein was shown to target several RTA repressor, like K-RBP (KSHV-RTA binding 
protein) and Hey1, a cellular transcriptional repressor, for polyubiquitination and proteasomal 
degradation. This RTA mediated repression of those two transcriptional repressors was shown 
to be essential for the reactivation of lytic DNA replication (84, 85) 
 
 
1.1.17  Immune response 
 
In addition to altering the cell cycle, viruses manipulate CRLs to interfere with the immune 
response of the host cells. HIV-1 (Human immunodeficiency virus 1) encodes the Vpu-
protein, which functions as a substrate-binding module in the SCF complex. The Vpu 
modified CRL induces the polyubiquitination of the CD4 receptor in the ER-membrane, 
which causes its cytosolic translocation and proteasomal degradation. CD4 functions as a co-
receptor for the TCR (T-cell receptor). Both receptors together mediate adaptive immunity by 
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binding to MHC class I (86).  
Viruses often activate the antiviral interferon response during infection. The JAK-STAT 
pathway is an interferon induced cytokine signaling pathway in mammals and a key player in 
antiviral defense. STAT (signal transducer and activator of transcription) proteins comprise a 
family of transcription factors important in cell growth, survival and differentiation, which get 
activated after pathway induction. The rubulavirus encoded V protein serves as a substrate-
targeting module in a Cul4a based CRL. It also binds directly to STAT2 (for human 
parainfluenza virus type 2) or STAT2 can be used to recruit STAT1 (for simian virus 5 and 
mumps virus). STAT2 or the heterodimer STAT1/STAT2 get connected to the CRL via the V 
protein and in following polyubiquitinated as signal for proteasomal degradation (87).  
The mumps virus encoded V protein was shown to target STAT3 directly via this above 
described composition, also as mechanism to diminish the antiviral response (88).  
There are also viral proteins known, which dislocate unwanted proteins from the ER. The 
HCMV (human cytomegalovirus) encoded US11 and US2 proteins dislocate MHC-I from the 
ER to the cytosol, were it becomes polyubiquitinated and proteasomal degraded (89).  
Also the KSHV (Kaposi's sarcoma herpes virus) encoded proteins K3 and K5 have been 
shown to down-regulate MHC-I mainly on the cell surface. K3 and K5 are membrane proteins 
containing an N-terminal located E3-ligase domain, which adds K63- linked Ub chains to 
MHC-I, mediating its endosomal sorting and lysosomal degradation (90). The destruction of 
MHC-I decreases antigen presentation to T cells, avoiding immune recognition. The CD4 
receptor is a co-receptor, which assists the TCR (T cell receptor) of helper T-cells by antigen-
presenting cell recognition essential for innate immunity activation. After cellular CD4 
synthesis, the protein gets located within the ER-membrane and sorted to the cell outer 
membrane. The HIV encoded Vpu protein is a transmembrane protein, which is also 
integrated into the ER-membrane. It binds to CD4 and TRCP, a substrate targeting module 
in the Cul1 based SCF complex. This CRL interaction modulates CD4 polyubiquitination and 
proteasomal degradation, resulting in inefficient antigen-presenting cell recognition of helper 
T-cells (91).  
As described above, induction of ISG15 expression upon viral infection appears to be a 
broad-spectrum inhibitor of virus production. Influenza B virus infection causes strong 
induction of ISG15 expression. Its viral encoded NS1 protein was found to bind to ISG15, 
preventing it from binding to its E1 activating enzyme UBE1L, causing inhibition of cellular 
ISGylation (92). 
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1.1.18  Viral budding 
 
RNA viruses, like HIV-1 and RSV (Rous sarcoma virus) complete their replication cycle by 
forming vesicles that bud from the plasma membrane. The Gag polyprotein has been reported 
to be necessary and sufficient for the assembly and budding of virus-like particle. A central 
located Gag protein domain, called L (late) domain, was reported to bind to cellular proteins 
involved in the host VPS (vacuolar protein sorting) pathway, a cellular budding process that 
formats multivesicular bodies, very similar to virus budding. Among those recruited cellular 
proteins are Nedd4-family E3 ligases, which have been shown to facilitate ubiquitination of 
the viral Gag-protein. Gag ubiquitination is correlated with successful virus release, also 
facilitating its own sorting into viral vesicles as they bud from the plasma membrane (93). 
Tsg101 (tumor supressor gene 101) is involved in vascular protein sorting and multivesicular 
body biogenesis by binding to monoubiquitinated proteins. Also Tsg101 was shown to bind to 
the ubiquitinated Gag protein by binding to Gag and ubiquitin. This interaction was shown to 
be essential for viral budding and release of HIV and Ebola virus (94).  
These above described findings emphasize the pivotal role of Ub/UbL 
conjugation/deconjugation in modulating critical aspects of the virus-host cell interaction. 
 
 
1.1.19  Introduction to EBV 
 
EBV is a 172 kb long double-stranded DNA tumor virus, which establishes latent infections 
in 90% of the human population worldwide. Infection occurs in most cases during childhood 
with no or mild symptoms. Infection occurring in adulthood is known to cause a benign 
lymphoproliferative disease called “infectious mononucleosis”. This viral illness is 
characterized by moderate symptoms like fever, sore throat and swollen lymph glands. EBV 
is associated with a variety of malignancies of lymphoid cells, like Burkitt´s lymphoma, 
Hodgkin´s lymphoma and NK- and T-cell- lymphomas as also of epithelial cells, like 
nasopharyngeal carcinoma and gastric carcinoma. Like other herpesviruses EBV has a latent 
and a lytic life cycle. Epithelial cells of the oropharynx are the site of primary infection and 
are also believed to be the major site for viral replication. B-lymphocytes have been shown to 
serve as sites for the viral latent cycle and life long persistence. The EBV-genome does not 
normally integrate into the cellular DNA but persists as circular episome in the host cell. The 
viral latency comprehends the expression of a subset of latent proteins and an array of  
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transcribed non-coding RNAs (EBERs) and microRNAs depending of the type of latency 
(Type I, II, III). Those nine latent proteins are comprised of six “EBV nuclear antigens”, 
called EBNA-1, -2, -3A, -3B, -3C and LP and three “latent membrane proteins”, called LMP-
1, -2, and -3. The viral latency is well studied and understood to a higher degree then the 
regulation of the viral lytic phase (95, 96).  
Upon induction of the lytic phase the first detectable expressed proteins are the two 
immediate-early gene products BZLF1 and BRLF1. Both proteins transactivate viral 
promoters, which leads to an ordered cascade of viral early and late gene expression. Early 
gene products include proteins involved in viral DNA replication and DNA metabolism. The 
lytic phase of DNA replication is dependent on seven viral replication proteins: BZLF1, 
binding to the oriLyt (origin of lytic phase); BALF5, a DNA polymerase; BMRF1, a 
polymerase processivity factor; BALF2, a single-stranded DNA-binding protein and BSLF1, 
BBLF4, BBLF2/3 proteins comprising a primase-helicase complex. Viral lytic replication 
occurs in discrete nuclear sites, named replication compartments, in which viral replication 
proteins are assembled. Induction of the EBV lytic program results in inhibition of cellular 
DNA replication as well as explosive replication of viral DNA (97). 
 
 
1.1.20  The role of  ubiquitin and UbL-modifiers in the EBV life cycle 
 
Nedd4 ubiquitin ligase family members have been reported to have a function in the 
maintenance of EBV latency in B lymphocytes. The BCR (B cell receptor) is known to 
mediate reactivation of the lytic cycle from the latent state. This is achieved by BCR cross-
linking resulting in activation of signaling pathways, which initiates the viral transactivator 
BZLF1. Among others Lyn and Syk are two cytoplasmic tyrosine kinases, which upon 
binding to activated BCR mediate activation of BZLF1. The viral latent protein LMP2A 
contains two PPPY motifs, which were shown to recruit Nedd4 family members. After 
LMP2A binding to Lyn and Syc the recruited Nedd4 E3 ligases facilitate the 
polyubiquitination of those two tyrosine kinases, which causes their proteasomal degradation. 
The depletion of Lyn and Syk prevents signaling of activated BCR resulting in the 
maintenance of the latent cycle (98).  
The lytic switch gene BZLF1 was found to be modified by SUMO-1. Unconjugated SUMO-1 
level in cells are quite low. It has been shown, that BZLF1 competes with the PML-protein 
for SUMO-1 required for their both modification. By doing so BZLF1 degreases PML-protein 
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sumoylation, causing the inhibition of PML body formation. Among others PML body 
formation is induced by type I and II interferons, induced upon viral infection, suggesting a 
function with an antiviral capacity. The disruption of PML bodies, which was demonstrated 
by all classes of herpesviruses, suggests that this function is important for efficient lytic 
replication. It has also been shown, that sumoylation of BZLF1 decreases its transactivating 
ability (99). BZLF1 was also shown to serve as a substrate binding module in a Cul2 and Cul5 
based CRL. Those assembled CRLs were reported to target p53 for polyubiquitination and 
proteasomal degradation (100) as described already for other viruses above.  
EBNA3C is a critical component
 
for EBV immortalization of infected B lymphocytes. 
EBNA3C was found to be modified with SUMO-1 and upon this modification co-localized 
with PML nuclear bodies. This co localisation was shown to decrease the effect of PML body 
formation, possibly due to competition among PML and EBNA3C for limited free SUMO-1 
resources. The site of sumoylation was elucidated by usage of an EBNA3C truncated form. 
An EBNA3C 343-545 was not able to undergo sumoylation and did not co localize with 
PML nuclear bodies. Since EBNA3C transcriptional activation is mediated by amino acids 
365 to 545, which are
 
required for binding to SUMO, EBNA3C modification with SUMO 
could be important for EBNA3C described transcriptional
 
effects (101). EBNA3C was also 
shown to interact with the Rb protein and to facilitate its proteasomal degradation via the 
SCF-Skp2 complex. Overexpressed EBNA3C into EBV negative epithelial and lymphoid cell 
lines resulted in decreased Rb protein level. It has been shown, that the ability of EBNA3C to 
facilitate the degradation of Rb was down regulated by expression of a dominant negative 
SCF-Skp2 complex. No down regulation of Rb was detected in the absence of EBNA3C 
(102).  
Most intracellular proteins are destroyed via polyubiquitination mediated degradation in the 
proteasome. Resulting peptide fragments of degraded antigens are presented at the cell surface 
in association with MHC-I for immune recognition (103). EBNA1 is the most prominent 
latent protein of EBV with the broadest array of function. It is known to be essential for the 
maintenance of the viral genome, transcription and translation of the viral DNA, viral host 
persistence and cellular transformation. It has been demonstrated, that the internal Gly-Ala 
repeat domain of EBNA1 was able to interfere with the proteasome resulting in its protection 
from degradation. As a result, no EBNA1 peptide fragments are assessable for MHC-I 
binding and presentation on the cell surface, impairing immune recognition (104). EBNA1 
has also been shown to interact with the DUB USP7, which has also been described to 
deubiquitinate p53 and its E3 ligase Mdm2. EBNA1 and p53 compete for the same interaction 
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site on USP7. EBNA1 was shown to have a 10 fold higher affinity to the USP7 binding site 
then p53, being able to control p53 binding and deubiquitination. Functional studies were able 
to show, that binding of EBNA1 to USP7 was able to protect cells to undergo apoptosis by 
lowering p53 levels (105).  
Most substrates are ubiquitinated on lysine residues, although ubiquitination on Cysteine and 
Serine residues as the ubiquitination of N-termini has also been reported. A database search 
identified several lysine free viral proteins, with lysine rich cellular and viral homologues. It 
is believed, that the comprehension of Lysine less proteins could be advantageous to viruses 
to protect them from polyubiquitination mediated degradation. The EBV encoded BHRF1 
protein is a lysine less protein and a Bcl2 (B-cell lymphoma 2) family member. Bcl2 as 
BHRF1 are responsible for the release of mitochondrial cytochrome C, controlling cellular 
apoptosis (106, 107). It was shown in apoptotic cells, that Bcl2 was polyubiquitinated and 
degraded. To elucidate the impact of the lysine residues within Bcl2 concerning its described 
function, all lysines were removed via site-directed mutagenesis. It was demonstrated, that 
this lysine less Bcl2 mutant was resistance to degradation and was able to inhibit cell 
apoptosis (108). It could be speculated, that the lysine less BHRF1 is also able to escape 
ubiquitination and degradation with resulting pro-apoptotic conditions.  
LMP1 is one of the EBV gene products, which are essential for B-cell transformation. It is 
also the only EBV protein that has oncogenic potential in non-B cells. The family of IRFs 
(Interferon regulatory factors) comprise transcription factors, which are predicted to 
contribute to EBV oncogenesis through regulation of a spectrum of oncogenes or apoptosis 
related genes. IRF7 is a central regulator of type 1 IFN-mediated innate and adaptive immune 
responses. It has been shown that IRF7 is modified from TRAF6 with K63-linked 
polyubiquitin, which protects the protein from proteasomal degradation and also causes its 
transcriptional activation. TRAF6 is a member of the TRAF protein family, which are 
involved in signal transduction controlling both innate and adaptive immune responses. 
TRAF6 has also been shown to comprise E3 ubiquitin ligase activity. TRAF6 and its E3 
ligase activity are required for LMP1 stimulated IRF7 ubiquitination. A20 is an enzyme with 
dual function, comprising DUB and E3 ubiquitin ligase activity in one protein. Further it has 
been shown that LMP1 induces A20, which upon induction negatively regulates IRF7 
transcriptional activity by deubiquitinating IRF7. A DUB deficient truncation or point 
mutation reduced the ability of A20 to inhibit IRF7, a ligase mutant didn’t show any effect. 
Knockdown of A20 resulted in an increase in endogenous IRF7 K63-linked 
polyubiquitination and transcriptional activation (109, 110). 
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Upon EBV infection, several cellular DUBs are known to increase in activity including USP-
5, -7, -13, -15 and -22. Those DUBs recruited by EBV may stabilize -catenin in latently 
infected B-cells. -catenine is a key component of the Wnt signaling pathway that regulates 
growth and differentiation of cells. Wnt signaling deregulation has been implicated in cancer 
development and could also play a role in EBV associated cancer development (111).  
An overview of all the interactions of EBV with the cellular ubiquitin and ubiquitin like-
modification system introduced above, are visualized in figure 2. 
 
 
Figure 2. EBV encoded ORFs interfere with the ubiquitination and UbL-modification system at different sites.  
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1.2  INTRODUCTION – AmotL2 in control of cell topology  
 
 
1.2.1  Epithelia 
 
During embryonic development single cells join together to form functional units or organs. 
The Epithelium is a highly packed and dense tissue, which separates cavities and covers 
surfaces of newly formed organs. Epithelial tissues serve as a barrier against pathogens and 
support the structure of organs. The epithelium does not only protect from e.g. mechanical 
injury (skin) but also facilitates diffusion of oxygen and CO2 in lungs, produces milk in glands 
and absorbs nutrients in the intestine. Three major groups of epithelia can be classified [1] by 
their number of cell layer (one layer: simple epithelium; more than one layer: stratified 
epithelium), [2] by the form of their cells (columnar-, cuboidal-, and squamous-epithelium) 
[3] and by the form of the cells at the outer layer (stratified columnar-, stratified cuboidal-, 
and stratified squamous-epithelium).  The simple squamous epithelium which lines blood and 
lymphatic vessels is called endothelium. These different types of cell layers depend on the 
strict regulation of their cellular shapes and morphology for proper function (Cooper 2000, 
Guillot and Lecuit 2013). 
Studies of epithelial function are of importance as they may provide clues regarding the 
development of novel therapies against human pathologies. For example, the majority of 
human cancers arise in tissues of epithelial origin and account for more than 80% of all 
cancer-related deaths. A strong correlation between loss of epithelial organization and 
malignancy has been documented for most carcinomas. The loss of tissue organization may 
be attributed to the deregulation of the normal mechanisms that are essential for epithelial 
morphology. These include the control of apical-basal polarity, cell-cell contacts and the 
cytoskeleton (Wodarz and Nathke 2007, Muthuswamy and Xue 2012).  
In this section, I will describe the different components that are of importance for epithelial 
architecture and how the Angiomotin protein family integrates these pathways.  
 
 
1.2.2.  Cell polarity  
 
The generation of three-dimensional epithelial structures in organs such as colon, prostate and 
skin depends on the establishment of cell polarity. This complex cellular mechanism is the 
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result of the asymmetric distribution of different polarity protein complexes. The two main 
complexes PAR (Cdc42/Par3/Par6/aPKC) and Crumbs (Crb/Pals1/PATJ) are e.g. involved in 
the establishment and maintenance of apical-basal cell polarity and also facilitate a possible 
depolarization. The core protein complex Scribble (Srib/Lgl/Dlg) promotes the baso-lateral 
membrane formation (Bryant and Mostov 2008, Roignot, Peng et al. 2013). 
Polarity processes leading to a stationary epithelium are discussed below. During this 
development the small GTPase Cdc42 plays a central role. This protein is a member of the 
Rho-GTPase family and has an astonishing ability to control and coordinate several signal 
transduction pathways. It functions as a molecular switch, changing from its inactive state 
(bound to guanosine diphoshate, GDP) to its active state (bound to guanosine triphosphate, 
GTP). The recharging of GDP to GTP and therewith “switching on” of Cdc42 is facilitated by 
Guanine nucleotide exchange factors (GEFs) (Cooper 2000, Etienne-Manneville 2004).  
Filopodia are cytoplasmic extensions that elongate beyond the leading edge of lamellipodia in 
migrating cells. Filopodia formation is accomplished by Cdc42 binding to the WASp protein, 
which recruits and activates the Arp2/3 complex (Magdalena, Millard et al. 2003).  
In epithelial cells filopodia have been demonstrated to establish cell-cell contacts leading to a 
polarized morphology, by enabling cell-cell junction assembly (Vasioukhin and Fuchs 2001). 
In multicellular organisms, cell polarity is initiated mainly by external stimuli. Membrane 
receptors, which facilitate adhesion, such as cadherins, nectins and integrins, as well as 
chemokine receptors (soluble ligand receptors) sense their environment in order to establish 
polarity (Etienne-Manneville 2004).  
During the process of polarization and epithelial sheet formation, cells generate distinct cell 
membrane compartments, which are localized to the apical (facing the lumen), or baso-lateral 
(facing the extracellular matrix and neighboring cell) cell surfaces (Rojas, Ruiz et al. 2001). 
This process is initiated by adhesion proteins such as E-cadherin and nectin (Takai and 
Nakanishi 2003). Their ligation induces Cdc42 activation by e.g. the activation of the GEFs 
FRG and Vav2 ( Fukuhara, Shimizu et al. 2004).  
The establishment and composition of the two different apical and baso-lateral membrane 
domains is regulated by the endocytic and exocytic secretory pathway. Cdc42 has been 
proposed to regulate the exit of apical and baso-lateral proteins from the trans-Golgi network 
(Musch, Cohen et al. 2001). This process may involve the establishment of the Par6-aPKC 
and Lgl-scribble polarity complex components to the plasma membrane. Lgl has been shown 
to interact with the membrane integrated Q-SNARE protein t-SNARE syntaxis 4 and regulate 
baso-lateral exocytosis (Musch, Cohen et al. 2002). The activity of the apical polarity protein 
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Crb is needed for vesicle exocytosis at the apical surface (Myat and Andrew 2002). The 
Sec6/Sec8 polarity complex, which is located just below the tight junctions, is involved in the 
baso-lateral delivery of proteins in epithelial cells (Matern, Yeaman et al. 2001, Kreitzer, 
Schmoranzer et al. 2003). 
The p65PAK family of serine/threonine kinases is one of the best studied Cdc42 targets. 
p65PAK localizes to cell-cell adhesion contacts in epithelial cells and controls polarized actin 
polymerization. This process is facilitated by regulating LIM kinases which phosphorylate 
and inactivate the actin binding protein cofilin leading to a polarized actin rearrangement 
(Bokoch 2003, Edwards, Sanders et al. 1999).  
 
 
1.2.3  Cell-cell adhesion 
 
Epithelial cells are attached to eachother at contact points called cellular junctions. These 
contact points fall into different categories, the tight junctions, the adherens junctions, the 
desmosomes and the gap junctions, each with individual functions (Figure 1) (Cooper 2000). 
 
 
1.2.4  Tight junctions 
 
In epithelia, tight junctions (TJ) are found at the most apical site of the lateral membrane, 
were they form an impermeable intramembranous barrier to fluid. This is of importance for 
e.g. the maintenance of the osmotic balance in tissues (Aijaz, Balda et al. 2006). Apart from 
facilitating cell-cell adhesion, TJ have been associated to intracellular signaling mechanisms 
which influence polarization, cell proliferation and differentiation (Zahraoui 2004, Shin, Fogg 
et al. 2006). TJ are assembled out of two different types of transmembrane proteins. Those are 
the tetraspan- (occluding, tricellulin and claudins) and the singlespan- (e.g. JAMs, CAR, 
CLMP and CRB3) transmembrane proteins (Bazzoni 2003, Aijaz, Balda et al. 2006). 
Towards those mentioned transmembrane proteins binds a so called “cytoplasmic plaque”, 
which are adaptor-, cytoskeletal or scaffolding proteins which mainly cross links the 
junctional transmembrane proteins to the actin cytoskeleton. Those “plaque” proteins regulate 
adhesion and paracellular permeability as they transmit signals from the junctions towards the 
cellular inner controlling gene expression and migration. The TJ plaque also recruits an array 
of signaling proteins, which includes kinases and phosphatases involved in gene expression 
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regulation. Some of the most prominent TJ plaque proteins are ZO1, PAR3, PAR6, Pals1 and 
PATJ (Assemat, Bazellieres et al. 2008, Balda and Matter 2008, Guillemot, Paschoud et al. 
2008, Paris, Tonutti et al. 2008). 
 
 
1.2.5  Adherens junctions 
 
Adherens junctions (AJ) are located below the tight junctions on the apical lateral side 
between two neighboring epithelial cells. During cell-cell contact formation AJ are the first 
junctions to be formed which then promotes the subsequent development of tight junctions. 
The main feature of AJ is to facilitate cell-cell adhesion via the establishment and 
maintenance of a circumferential actin belt, which connects single epithelial cells to tightly 
packed epithelial sheets. This actin belt, also called “adhesion belt” is involved in epithelial 
morphogenesis mediation as it also facilitates the transmission of subcellular force (Harris and 
Tepass 2010, Guillot and Lecuit 2013).  
The formation of AJ is mediated by homotypic interactions of the transmembrane adhesion 
molecule E-cadherin between two neighboring epithelial cells. Their extracellular domain is 
arranged into five repetitive domains, which contain calcium-binding sites (Overduin, Harvey 
et al. 1995). Calcium facilitates homotypic adhesive activity, enabling a dynamic regulation 
of adhesive contacts (Nagar, Overduin et al. 1996).  
The cytoplasmic tail of E-cadherin associates to plaque proteins like p120, α- , β- catenin and 
plakoglobin, which in return mediate binding to contractile actin fibers forming e.g. the 
adhesion belt (Baum and Georgiou 2011).  
AJ serve as a start and fixing point for cell polarity. Apical polarity proteins like Crb3, 
PALS1, PATJ, PAR3 and aPKC are found in high concentration just above the AJ as 
basolateral proteins like LGL, DLG and Scrib are found just below AJ (Georgiou and Baum 
2010).  
The mechanisms how cadherins connect to actin have been a subject of controversy. It was 
long thought that cadherins bind to β-catenin by associating to α-catenin which acted as a 
linker between the adhesion complex and the cytoskeleton.  This dogma was later revised 
based on the findings that α-catenin does not bind β-catenin and actin fibers simultaneously 
(Drees, Pokutta et al. 2005). Apart from the circumferential actin belt, a second population of 
contractile actin fibers was described to localize to the junctions (Zhang, Betson et al. 2005). 
How E-cadherin connects to contractile actin filaments that run perpendicular to the cell-cell  
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junctions is the topic of paper III in this thesis. 
Epithelia are very dynamic and underlie steady changes of tissue organization. Constant 
changes due to cell tissue reorganization, differences in cell packing and apoptosis requires an 
ongoing forming and disassembly of AJ. This procedure is e.g. carried out by a very active 
internalization and recycling back of E-cadherin from and to the plasma membrane. This 
process has been shown to depend on clathrin-mediated endocytosis (Bryant and Stow 2004). 
It has also been demonstrated, that the recycling of E-cadherin requires the octameric protein 
exocyst complex for the delivery of the protein to the AJ (Blankenship, Fuller et al. 2007, 
Baum and Georgiou 2011).  
The transmission of mechanical signals through AJ leading to intracellular signaling cascades 
will be discussed in the following chapter “mechanotransduction”.  
A further AJ component is the transmembrane protein family of the nectins which promote 
cell-cell adhesion in a calcium independent manner. Similar to E-cadherin, they undergo 
homophilic interactions between two neighboring cells with their extracellular regions. They 
connect via their cytoplasmic regions to the actin binding protein afadin, which in turn binds 
to actin fibers. Nectin mediated cell adhesion is involved in the induction of polarity, as it 
induces the formation of adherens junctions in epithelial cells, by the activation of Cdc42 and 
Rac small G proteins, which in turn reorganize the actin cytoskeleton. Nectins also bind to the 
polarity protein PAR3 with their cytoplasmic regions (Takai, Irie et al. 2003, Nakanishi and 
Takai 2004).  
 
 
1.2.6  Desmosomes and Gap junctions 
 
Desmosomes are intercellular junctions that connect cellular intermediate filaments to the 
plasma membrane. Those adherence platforms are primarily present in tissues with higher 
exposure to shear stress, like in epithelia, were they support stable cell-cell adhesion. The 
adhesive parts of desmosomes are assembled out of two different kind of transmembrane 
proteins, the desmogleins and desmocollins, which are calcium dependent members of the 
cadherin family. Towards the cytosolic tails of the adhesive proteins bind cytosolic adaptor 
proteins (desmosomal plaque) which are e.g. plakophilins and plakoglobin, which are 
members of the armadillo gene family. Those adaptor proteins bind to intermediate filament 
binding proteins like desmoplakin which link the desmosomal protein complex to the 
filaments (Delva, Tucker et al. 2009, Kowalczyk and Green 2013).  
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Gap junctions are clusters of intercellular channels that facilitate a direct transfer of ions, 
amino acids, second messengers and electrical signals between neighboring cells. Due to this 
direct shuttling mechanism gap junctions enable cellular key events like apoptosis, cell 
differentiation and tissue homeostasis (Nicholson 2003, Nielsen, Nygaard Axelsen et al. 
2012).  Gap junctions are found in all kind of adhesive tissue cells where they are assembled 
out of connexins (Cx) which are integral membrane proteins (Goodenough, Goliger et al. 
1996). Each gap junction is assembled out of two hemichannels, also called connexons, 
whereby each hemichannel is constructed out of six connexin molecules. The major gap 
junction regulating mechanism is phosphorylation, which is vital for gap junction assembly, 
turnover and function (Warn-Cramer and Lau 2004). 
 
 
 
Figure1. Polarized epithelial cells of a simple epithelium visualizing cell-cell adhesion sites. Kindly provided 
from Nature Publishing Group.  
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1.2.7  Adhesion to the extra-cellular matrix 
 
The extra cellular matrix (ECM) is a complex composition of matrix molecules (e.g. 
collagens, fibronectin, glycoproteins, laminins, proteoglycans) and non-matrix proteins (e.g. 
growth factors, kinases, phosphatases, proteases) (Naba, Hoersch et al. 2012). The main 
functions of the ECM are the structural support (e.g. cell migration and polarization), the 
regulatory function (e.g. tissue organization and differentiation) and the supply of nutrients to 
the attached cells. Epithelial cells bind to the ECM mainly via integrins, which are membrane 
adhesion proteins located on the basal cell membrane (Berrier and Yamada 2007). Integrins 
are heterodimers built up out of an α- and β- subunit. In mammals 18 α-  and 9 β- subunits  
are expressed, assembling to 24 specific integrin receptors, which bind different ECM ligands 
(e.g. collagen, fibronectin and laminin) with various affinities (Luo, Carman et al. 2007). The 
main two functions of integrins are the attachment of the cell to the ECM and the signal 
transduction vice versa. Several integrins accumulate to clusters which are called “focal 
adhesions”. Towards the cytosolic cell site integrins are linked mainly to the actin 
cytoskeleton via a variety of adaptor proteins (vinculin, talin and α-actinin) (Brakebusch and 
Fassler 2003). Apart of that several signaling proteins bind to the cytosolic site of integrins 
which are involved in various signaling cascades controlling e.g. cell migration, 
differentiation, gene regulation, polarity and proliferation (Harburger and Calderwood 2009). 
These kinds of signaling events will be discussed further in the chapter 
“mechanotransduction”. Integrins are also involved in a process called “inside-out signaling” 
were intracellular signals are able to induce alterations in integrin conformation and activity 
leading e.g. to the loss of the cell from the ECM (Luo, Carman et al. 2007).  
Epithelia also exert adhesion structures called hemidesmosomes to facilitate cellular 
adherence from the cellular keratin cytoskeleton to the basement membrane, which is a 
specialized form of the ECM (Seltmann, Roth et al. 2013). Those adherence structures are 
assembled within the basal cell membrane via the two transmembrane proteins α6β4 integrin 
and BP180. The connection to the cellular keratin network is realized by the inner plaque 
proteins HD1/plectin and BP230. Apart from their function to master cellular adhesion, 
hemidesmosomes are also involved in mechanotransduction, by outside-inside signaling 
mainly via signal transduction trough the α6β4 integrin. Those mediated signals have been 
demonstrated to be involved in regulating vital cellular processes like apoptosis, 
differentiation and proliferation (Mainiero, Pepe et al. 1995, Nievers, Schaapveld et al. 1999). 
  
29 
 
 
 
 
1.2.8  Cytoskeleton  
 
The cytoskeleton is a protein fiber skeleton imbedded within the cytoplasm of all kinds of 
cells (prokaryotes and eukaryotes). In eukaryotes it is constructed out of three different kinds 
of protein filaments, the actin filaments (also called microfilaments), the intermediate 
filaments and the microtubules. All three cytoskeletal fibers are homogenous structured 
polymers, constructed from individual monomeric protein subunits connected via non-
covalent bonds. The main function of the cytoskeleton is to physically enable a certain cell 
morphology and to allow morphological changes e.g. during cell division or migration. It also 
serves as a mediator of intracellular vesicle trafficking (Cooper 2000).  
 
 
1.2.9  Actin filaments 
 
The actin filaments are polar structures buildup of monomeric subunits called globular actin 
(G-actin). Those monomers are linear head-to-tail polymerized to flexible filamentous actin 
(F-actin) fibers, 6 to 9 nm in diameter and up to several micrometers in length. During 
assembly of filamentous actin, the G-actin monomers are rotated by 166
o
, creating a fiber 
form of a double stranded helix. Those created actin fibers are organize into two types of 
structures, actin bundles or actin networks, facilitated by different actin crosslinking proteins, 
determining the physical properties of those structures (Giganti, Plastino et al. 2005, Winder 
and Ayscough 2005).  
Actin bundles are parallel arrays of actin fibers tightly packed by actin crosslinking proteins. 
Three-dimensional actin networks are constructed out of loosely linked actin filaments 
obtaining the properties of semisolid gels. Actin filaments bind to the motor protein myosin, 
which enables them to contract. Myosin hydrolyses ATP to ADP to generate force and 
movement, e.g. used for cell migration or muscle contraction (Hill, Catlett et al. 1996). 
Contractile actin bundles, also called stress fibers, connect e.g. epithelial cells to the ECM by 
being linked to integrins assembled in focal adhesions. Most stress fibers are bound to myosin 
II motors, which enables them to contract making them to indispensable components to cell 
adhesion and morphogenesis (Tojkander, Gateva et al. 2012). 
In a polarized epithelium actin bundles, named adhesion belt, interconnect the adherens 
junctions within a cell. They are linked via a subset of actin binding proteins to the 
transmembrane adhesion protein E-Cadherin. Their main function is to connect single 
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polarized epithelial cells to tightly packed epithelial sheets, contributing to establish the 
needed mechanical strength and enabling the transmission of subcellular force (Harris and 
Tepass 2010, Guillot and Lecuit 2013).  
Contractile actin bundles, distinct from the adhesion belt fibers, were also described to 
localize to the junctions (Zhang, Betson et al. 2005).  
The apical side of epithelial cells can contain protrusions which are involved in absorption of 
nutrients. Those surface extensions are based on actin filaments arranged in bundles or 
networks. An example of those surface protrusions are microvilli, which are formed on the 
apical surface of epithelia lining the intestine. Each of those intestine epithelial cells contains 
ca. 1000 microvili structures increasing the nutrient absorbing apical surface by the factor 10 
to 20. Other actin based cell surface protrusions, like pseudopodia, lamellipodia or filopodia 
are formed on the leading edge of a moving cell and enable cell locomotion (Cooper 2000, 
DeRosier and Tilney 2000).  
 
 
1.2.10  Intermediate filaments  
 
Intermediate filaments (IFs) range in diameter between 10 – 12 nm and are assembled of a 
subset of proteins, which share common structural attributes. They are cytosolic filaments, 
except the lamins which form a nuclear lamina three-dimensional network (Goldman, 
Gruenbaum et al. 2002). Intermediate filaments are unpolar structures and assemble in most 
mammalian cells a network which fills out the entire cell. Keratin and vimentin based 
filaments connect to the nucleus, positioning and holding it in place. IFs interconnect also cell 
adhesion components in polarized epithelial cells.  Keratin filaments bind to the desmosomes 
and hemidesmosomes, thus mediating cell-cell and cell-matrix adhesion and thereby 
facilitating mechanical stability to the epithelium. IFs even connect to the other two 
cytoskeletal components, actin filaments and microtubules thereby enhancing the mechanical 
stability of the cell. IFs have also been described to modulate signals within a cell, e.g. by 
binding to the Fas cell surface receptor, modulating its density and function (Cooper 2000, 
Coulombe and Wong 2004, Herrmann, Bar et al. 2007). 
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1.2.11  Microtubule 
 
Microtubules are polar tubular structures, assembled by the globular protein tubulin. The 
inner diameter of a microtubule is about 12 nm and the outer diameter is about 25 nm.  
Apart from giving the cell mechanical support, microtubules enable cellular mitosis, were 
they form the mitotic spindle, responsible for the separation of the chromosomes (Fourest-
Lieuvin, Peris et al. 2006). Microtubules are able to develop directed force by assembling and 
disabling its own structure and by attaching to motor proteins like dynein and kinesin. Due to 
this characteristic microtubules are actively engaged in the cellular transport of membrane 
vesicles in the endocytic and secretory pathways as they also transport organelles, like Golgi 
apparatus, lysosomes and mitochondria within eukaryotic cells (Hirokawa 1998). Microtubule 
structures are able to assemble or disassemble in the shortest timeframe compared to the other 
cytoskeletonal structures, the actin filaments or intermediate filaments. In order to increase 
the stability of microtubules in certain regions of the cell, they bind to microtubule-associated 
proteins (MAPs). MAPs interconnect microtubule to intermediate filaments or other 
microtubule via a phosphorylation regulated mechanism. This microtubule stabilization at 
specific sites within the cell serves as an important step facilitating cell polarity and certain 
cell shapes (Cooper 2000, Siegrist and Doe 2007).  
 
 
1.2.12  Mechanotransduction 
 
Mechanotransduction describes the mechanisms by which cells translate mechanical cues into 
electrical or chemical based cell signaling events. Cells within multicellular tissues are 
exposed to an array of physical cues, like compression, expansion, shear stress and 
hydrostatic pressure. The exposed cells have to adapt to mechanical forces, resulting in e.g. 
changes in cell differentiation, growth, morphology and polarity (Huveneers and de Rooij 
2013). The way cells respond to the exposure to physical stimuli depends on the physical 
properties of the individual cell type and of the physical characteristics of the tissue they are 
imbedded in. The transfer of the mechanical stimuli towards the cell can occur from different 
locations. For epithelia those loci are mainly the ECM and cell-cell adherens junctions 
(DuFort, Paszek et al. 2011).  
Mechanical stimuli transmitted via the ECM are received mainly by integrins. They sense the 
nature and changes of the ECM surrounding and transmit signals via conformational changes 
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to cytosolic associated integrin plaque proteins like TALIN or BCAR1. Those sensor proteins 
paired with growth factor signalling (e.g  EGF)  are able to start specific cellular signalling 
events leading to cellular fate decisions influencing cell attachment, differentiation or 
migration (DuFort, Paszek et al. 2011).  
Elevated tension around focal adhesion contacts e.g. increases the clustering of integrins and 
the phosphorylation and activation of focal adhesion kinases (FAKs). This leads to the 
initiation of several cellular signalling events, like activating the Rho-family GTPases RhoA, 
which stimulate its effector RhoKinase/ROK/ROCK resulting in the assembly of new 
stressfibers by connecting actin filaments with myosin motors (Arthur, Noren et al. 2002).  
A further integrin mediated signalling pathway that is activated in response to mechanical 
force within the ECM is the MAPK–ERK pathway, which influences tissue development by 
regulating cell differentiation and proliferation (Yee, Weaver et al. 2008). The physical 
characteristics of the ECM are determined by the organization of its components and their 
degree of intramolecular crosslinking (DuFort, Paszek et al. 2011).  
Epithelia sense via intergrins the rigidity of the ECM, which they are attached to and adjust 
the tension they exert themselves accordingly (Saez, Buguin et al. 2005). When epithelia 
attach to stiff matrices they format larger focal adhesion clusters, binding to more actin 
stressfibers resulting in higher stabilizing traction forces within the cell. It also results in the 
destabilization of cell-cell adhesion points like adherens junctions, leading to the disruption of 
the actin “adhesion belt” (Tsai and Kam 2009, DuFort, Paszek et al. 2011). 
Cell attachment to stiff matrices also affects the microtubule rearrangement dynamics 
resulting in slow growing and long lasting microtubuli (Figure2b) (Myers, Applegate et al. 
2011) When epithelial cells attach to soft matrices, less integrin molecules are clustered 
leading to fewer establishments of integrin connected stressfibers and lower established 
traction forces. Also cell-cell junctions like tight and adherens junctions are fully matured 
including the successful formation of the adhesion belt, resulting in the establishment of a 
functional epithelium (Figure 2a) (DuFort, Paszek et al. 2011). 
Mechanosensing properties were also described at cell-cell adhesion sites. E-cadherin 
complexes were shown to be functional mechanosensors which transmit force between E-
cadherin and F-actin. This detected intercellular force overlapped with vinculin accumulation 
at actin-anchored cadherin adhesions, shown in imaging experiments. Vinculin potentiates the 
E-cadherin mechanosensory response, which was demonstrated by using E-cadherin based 
cell bead adhesion assays (le Duc, Shi et al. 2010).  
The motor protein myosin II is required for actomyosin contractility and for maintenance of 
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adherens junctions. In endothelial cells an increase of AJ size was detected after stimulation 
with activated myosin II and increasing tugging-force at the AJ. In those experiments myosin 
II level were downregulated via siRNA, which resulted in decreased traction force and AJ 
size. The tugging force was evaluated with a retooled version of elastomeric microneedles. 
Their data suggests that mechanosensitive growth is a basic mechanism for controlling AJ 
size and is similar to the observed growth of focal adhesions after applied force (Liu, Tan et 
al. 2010). 
Apart from the involvement of the actin cytoskeleton in the cadherin mechanoresponse, also 
the plakoglobin connected intermediate filaments towards cadherin based cell-cell junctions 
were described to facilitate mechanoresponces. Local pulling force was applied to 
Xenopus mesendoderm cell cadherin adhesions via C-cadherin coated magnetic beads and 
possible changes in cell polarity or migration were analyzed. This applied tension to the 
cadherin based adhesions induced traction forces directed to the opposite site of the applied 
force. This effect was induced by start of cellular migration caused by the new formation of 
polarized protrusions. Cadherins are associated to actin- and intermediate- filaments (IFs). By 
incorporating GFP labelled keratin into the Xenopus mesendoderm cells, strong GFP signals 
were detected at the cadherin cell - beads cadherin junctions. By impairing Keratin 
intermediate filament assembly through usage of antisense morpholinos, the before detected 
protrusive activity was perturbed (Weber, Bjerke et al. 2012).  
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Figure 2. Physical characteristics of the extracellular matrix (ECM) control cytoskeletal and junctional properties 
of polarized epithelial cells. Figure adapted from DuFort, Paszek et al. 2011, Nat Rev Mol Cell Biol. 
 
 
1.2.13  Angiomotin family 
 
The Angiomotin protein family of scaffold proteins comprises three members (Bratt, Wilson 
et al. 2002). The founding member angiomotin (Amot) was initially identified as a receptor 
for the angiogenesis inhibitor angiostatin. It was first described to be essential for endothelial 
cell migration (Troyanovsky, Levchenko et al. 2001). Amot sequence analysis showed that 
this protein was not similar to any known protein at the time and was found to belong to a 
novel protein family including AmotL1 (or JEAP) that was identified in a screen for 
endothelial junction proteins and AmotL2 (or LCCP) identified by homology searches in 
GenBank (Bratt, Wilson et al. 2002, Nishimura, Kakizaki et al. 2002). 
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Angiomotin family members have been found in human, mouse and zebrafish but not in 
Drosophila, yeast or bacterial genomes (Bratt, Wilson et al. 2002). These proteins act as 
scaffolds in that they contain interaction sites enabling the formation of protein complexes. 
The most conserved domain is the central coiled-coil domain which serves as an 
oligomerization site. Amot proteins form homo-oligomers and it has also been shown that 
Amot and AmotL1 can associate to form hetero-oligomers (Ernkvist, Birot et al. 2008, Zheng, 
Vertuani et al. 2009). 
Furthermore, the coiled-coil domain also allows the binding of the tumor suppressor Merlin 
which displaces Rich1, a small GTPase Activating Protein, and a positive regulator of Rac1, 
resulting in inhibition of Rac and Ras-MAPK pathways. These data indicate that Amot plays 
a critical role in mediating tumorigenesis caused by NF2 inactivation and could be exploited 
as a target in NF2-related cancers (Yi, Troutman et al. 2011). 
An important role in regulating cell polarity was indicated by the findings that Amot proteins 
associate to the Par3 and Crb3 polarity protein complexes via a C-terminal PDZ binding motif 
(Wells, Fawcett et al. 2006, Ernkvist, Luna Persson et al. 2009). Deletion of this motif 
abrogates protein-protein interaction resulting in loss of pro-migratory activity of Amot 
(Levchenko, Aase et al. 2003).  
The N-terminal domain of all three proteins contain conserved WW-binding motifs mediating 
the interactions to the tight junction protein MAGI1, the transcriptional co-activator YAP and 
the E3 ligase NEDD4 (Patrie 2005, Wang, Huang et al. 2011, Wang, An et al. 2012).  
Furthermore Amot has been demonstrated do bind F-actin in endothelial cells controlling 
cellular shape and AmotL1 has been shown to bind F-actin in epithelial cells promoting actin 
cytoskeleton remodelling (Ernkvist, Aase et al. 2006, Gagne, Moreau et al. 2009). The 
interaction partners of the Amot family suggest a role in coordinating and integrating polarity, 
cell-cell adhesion and cytoskeletal signalling pathways, which is of course of interest in 
understanding morphogenic events during normal and cancer development.  
Strategies to inactivate Amot in endothelial cells in vitro, as well as zebrafish and mouse in 
vivo have shown that Amot is essential for normal angiogenesis. The primary role appears to 
be the control of directional migration in response to angiogenic factors such as VEGF and 
bFGF. Knock-down of Amot in zebrafish results in loss of migration of inter segmental 
vessels which lack polarized protrusions of filopodia (Aase, Ernkvist et al. 2007).  
Similar findings have been observed in conditional inactivation of the Amot gene during 
retinal vascularization of postnatal mice. Here, migration and the extension of filopodia are 
also affected (Zheng et al., unpublished data). 
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Furthermore it has been reported, that Amot, AmotL1 and AmotL2 bind via their C-terminal 
located PDZ binding motif the RhoA GTPase exchange factor Syx. This binding was essential 
for endothelial cell migration, as the knockdown of Amot lead to inhibition of intersegmental 
vessel migration during zebrafish angiogenesis. Syx is expressed in endothelial cells and is 
dependent on Amot for spatiotemporal targeting of RhoA to the leading edge of migrating 
cells (Ernkvist, Luna Persson et al. 2009). 
It has been long known that tumor growth, invasion and metastasis are depending on the de-
novo formation of blood vessels. Different strategies have been employed to target Amot and 
tumor angiogenesis. The Holmgren and Cavallo labs have shown that Angiomotin DNA 
vaccination could prevent breast cancer outgrowth in a transgenic breast cancer model 
(Holmgren, Ambrosino et al. 2006, Arigoni, Barutello et al. 2012).  
 
 
 
 
Figure 3. Primary domain structure of AmotL2 p100 included binding sites and interacting proteins. 
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2.1.  AIMS OF THIS STUDY- EPSTEIN-BARR VIRUS ENCODED DECONJUGASES 
 
The general aim of the work presented in this thesis, was to elucidate and characterize novel 
deubiquitinating enzymes (DUBs) or ubiquitin-like proteases (ULPs) encoded within the 
genome of Epstein-Barr virus (EBV).  
 
More specifically, we wanted to: 
 
- develop a bacterial screening assay based on usage of Ub/UbL-modifier reporter constructs,     
to test the EBV-ORFeome for encoded functional DUBs and ULPs 
 
- characterize the discovered DUBs and ULPs via mutation analysis and usage of functional 
reporter and probes 
 
- elucidate the functional role of EBV encoded DUBs or ULPs in the viral life cycle,      
including detection of interaction partners  
 
 
2.2  AIMS OF THIS STUDY- AMOTL2 IN CONTROL OF CELL TOPOLOGY 
 
The general aim of the work presented in this thesis, was to elucidate the function of AmotL2 
p100 in epithelial cells.  
 
More specifically, we wanted to: 
 
- construct AmotL2 shRNA and produce AmotL2 shRNA carrying lentiviruses to produce 
stable transfected epithelial knockdown cell lines 
 
- investigate changes on cell shape and polarity in stable transfected AmotL2 KD´s in MDCK 
and CaCo2 cells, detected in 2D- and 3D- assays, assayed by fluorescence microscopy 
 
- investigate and detect AmotL2 p100 involved cellular pathways, using fluorescence imaging 
and Co-IP/pull-down strategies to detect pathway interacting proteins. 
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3.  RESULTS AND DISCUSSION 
 
3.1  Publication I  
 
"Epstein-Barr Virus encodes three bona fide ubiquitin-specific proteases" 
 
This publication was divided into a bioinformatics part and a biochemical orientated 
experimental part. The overall aim was, to predict in silico EBV encoded ORFs with distant 
functional homologues of human deubiquitinating enzymes (DUBs) using sequence analysis 
methods. Candidate ORFs were further characterized by detecting their functional ability to 
process an ubiquitin conjugated reporter and probe construct. In following the in silico 
detected catalytic active cysteines were confirmed via mutation analysis.  
 
Bioinformatics approach: 
EBV encodes approximately 100 ORFs were most of them remain to be functional 
characterized. Given the essential role of DUBs within a cell, as described in previous 
chapters, a bioinformatics orientated strategy was developed with the aim to predict viral 
DUBs with distant functional human homologues. Four search strategies based on sequence 
analysis were used to identify putative DUBs encoded in the EBV genome. 
(i) Sequence alignment with the conserved C- and H-boxes of known DUB families. As 
mentioned before, all DUBs contain conserved regions within their catalytic domains, which 
are for most of them located around the catalytic active cysteine and histidine, also called C- 
and H-boxes. In the case of the JAMM DUB family, which are metalloproteases, only H-
boxes are present. A data set containing the sequences of human DUBs was aligned to the 
EBV ORF-eome by using the program CLUSTAL W. This widely used multiple sequence 
alignment program starts by doing a pair wise sequence alignment. Afterwards it generates a 
phylogenetic tree, a branching diagram showing the evolutionary relationships among species. 
Thereafter the program uses the phylogenetic tree to carry out a multiple alignment. 
Subsequently, sequence alignment with the BLAST (Basic Local Alignment Search Tool) 
program was performed. BLAST belongs to the most used sequence analysis methods and 
enables homology detection using pair wise sequence comparison. The characteristics of this 
program are short running times with a minimal sacrifice to distant sequence relationships. 
The resulting scores from a BLAST search have a well-defined statistical interpretation, 
making it possible to discriminate real matches from background hits (112). 
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(ii) Pattern search of conserved catalytic domains is a family based method, which uses as 
search criteria the conserved sequence information assembled in a set of homologue proteins 
(113). Patterns are the occurrence of distinct amino acids, which are conserved throughout 
members of a certain protein family. In our study, family based search pattern were derived 
from the aligned C- and H-box sequences of the known human DUBs. Pattern search with 
those conserved boxes accomplishes a more stringed assessment of the possibility that 
identified domains might be true C- or H-box homologues.  
(iii) Hidden Markov Model (HMM)-based searches involve two steps. At first a statistical 
model from the sets of aligned sequences has to be build and second that model has to be 
compared to query sequences. HMM is a profile-based model, which is in general more 
sensitive than pair wise methods like described above. HMMs are “trained” to make use of 
position specific scoring matrices, which represent the distribution of amino acids at each 
position in the conserved domains of particular protein families (114). In our studies family 
specific HMMs were trained from the aligned C- and H-boxes of the different human DUB 
families.  
(iv) Identification of Cys and His residues that are conserved in homologues encoded by other 
members of the HHV (human herpes virus) family, followed by an HMM search was the last 
step of investigation. This analysis was based on the assumption that amino acid residues, 
which are critical for protein function, like enzymatic activity, may be conserved in the HHV-
family. In our studies we were able to locate conserved Cys and His residues in identified 
HHV-family ORF homologues by sequence comparison. In following the patches surrounded 
by the detected conserved Cys and His residues were searched for known DUB, C- and H-box 
patterns by using the DUB family specific trained HMMs.  
Via the above described search strategies several viral candidate ORFs were identified to 
comprehend possible DUB function. To select the most potential ORFs for following 
functional studies, scoring criteria were devised for each search, which were compiled in a 
global DUB score (see publication I for details). In total 16 EBV ORFs, which achieved the 
highest global DUB score, were selected for following functional studies.  
 
Biochemical approach: 
In order to evaluate the possible DUB function of the viral candidate ORFs we developed a 
bacterial screening assay. We cloned the candidate ORFs or ORF-domains in GST bacterial 
expression vectors and designed a reporter construct, which is comprised of Ubiquitin C-
terminal covalently linked with the N-terminus of GFP. Afterwards the Ub-GFP reporter 
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construct and one of the GST-tagged EBV-ORFs at the time were transformed into E.Coli. 
The enzymatic activity of the candidate ORF was assayed by co-expression of the Ub-GFP 
reporter construct. Cleavage of the Ub-GFP reporter was detected via SDS-Page and Western 
blotting by usage of a specific antibody against an epitope located on the GST protein. To 
check the positive cleavage of the reporter during each assay, a GST fused USP19 (human 
DUB) was used. Via this method three EBV candidate ORFs could be identified, which were 
able to cleave the Ub-GFP reporter significantly above background. The N-terminal fragment 
of BPLF1, a large tegumental protein with earlier described DUB activity conserved amongst 
the HHV-family (68) was able to cleave the Ub-GFP reporter to the highest degree. The EBV 
ORFs BSLF1, known to function as an EBV primase (117), and BXLF1, known to function 
as an EBV thymidine kinase (118), were also able to cleave the reporter.  
In order to further characterize their DUB activity, those three proteins were overexpressed in 
bacteria and in following purified. The purified proteins were assayed by detection of 
cleavage of the flurogenic substrate Ub-AMC. This substrate contains the flurophore AMC, 
which upon 380 nm wavelength excitation and cleavage of the conjugated Ubiquitin starts to 
emit fluorescence with a wavelength of 460 nm (115). All three EBV ORFs hydrolyzed Ub-
AMC with different kinetics suggesting different affinities for the substrate.  
The ability of BSLF1 and BXLF1 to cleave Ub-AMC was significantly improved when equal 
amounts of immunoprecipitated proteins expressed in mammalian cells were taken for the 
assay. This circumstance may be explained by the impact of possible posttranslational 
modifications in increasing the activity of BSLF1 and BXLF1, which are not achieved in 
bacteria.  
In order to further characterize the DUB activity of BPLF1-N, BSLF1 and BXLF1, the 
predicted catalytic active cysteine residues were mutated to alanine residues to obtain 
catalytic inactive proteins. These mutations were created by PCR mediated site-directed 
mutagenesis. Via this method the catalytic inactive protein mutants BPLF1_C61A, 
BSLF1_C819A_C824A and BXLF1_C491A were generated.  
According to the annotated functions of BPLF1, BSLF1 and BXLF1 those proteins are 
involved in DNA replication and nucleotide metabolism pathways (68, 69, 117, 118) that are 
known to be regulated by ubiquitination and UbL-modification (2, 8, 9, 10). The following 
publication (II) will discuss the essential role of BPLF1_N in virus replication. The DUB 
functions of BSLF1 and BXLF1 within the virus life cycle need to be investigated in further 
studies. 
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3.2  Publication II  
 
“A deneddylase encoded by Epstein–Barr virus promotes viral DNA replication by 
regulating the activity of cullin-RING ligases” 
 
The overall aim of this work was to elucidate the functional purpose of the discovered 
deneddylase activity comprised in the N-terminal fragment of the viral encoded BPLF1 ORF. 
We were able to confirm the deneddylase activity of BPLF1-N in different assays with 
different NEDD8 conjugated functional probes. We identified members of the cullin family as 
substrates of BPLF1-N´s deneddylase activity. We further elucidated the consequence of 
BPLF1-N binding and deneddylating cullins assembled in CRLs, which was the stabilization 
of CRL substrates involved in cell cycle regulation. We could show that this BPLF1-N 
controlled accumulation of replication regulating proteins was essential for an S-phase like 
cellular environment and endoreduplication in BPLF1-N expressing cells. We further could 
demonstrate that the impact of BPLF1-N expression on viral genome replication was 
controlled by one stabilized CRL substrate, the DNA licensing factor CDT1. 
 
In order to extend the scope of the bacterial screening assay we designed new reporter 
constructs. Apart from the Ub-GFP reporter, we further constructed NEDD8-GFP, SUMO1-
GFP, SUMO2-GFP, SUMO3-GFP and ISG15-GFP reporter by linking the C-terminus of the 
UbL-modifier covalently to the N-terminus of GFP. We used an EBV-ORF library, were the 
entire ORF or ORF-domains were cloned into GST-bacterial expression vectors. The assay 
was performed by expressing the particular Ub/UbL-reporter construct together with one of 
the GST-tagged EBV-ORFs in E.Coli bacteria. The possible cleavage of the Ub/UbL-GFP 
reporter was detected via SDS-PAGE and Western blotting by usage of a specific antibody 
against an epitope located on the GST protein. The most striking outcome of this assay was, 
that the N-terminal fragment of BPLF1 was able to process the NEDD8-GFP reporter with 
similar efficiency as the Ub-GFP reporter.  
In order to characterize further the novel discovered deneedylase activity of BPLF1, we 
performed further functional assays. We detected, that bacterial expressed GST-BPLF1-N 
processed the flurogenic substrates Ub-AMC and NEDD8-AMC with equal efficiency. We 
compared the ability of eukaryotic expressed BPLF1-N to bind to the Ub-VS and NEDD8-VS 
functional probes. Those probes are used to characterize catalytic active cysteine 
deconjugases (32). The interaction of the probe towards the enzyme can be visualized by a 
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shifted enzyme protein band in a Western Blot. As a result we detected, that BPLF1-N was 
able to bind both probes with comparable efficiency.  
Taken together all three functional assays with the functional reporter and probes 
Ub/NEDD8-GFP, Ub/NEDD8-AMC and Ub/NEDD8-VS suggest similar affinities for 
BPLF1-N towards ubiquitinated and neddylated substrates.  
Next we addressed the question, if BPLF1-N was able to deneddylate cellular proteins in vitro 
and in eukaryotic cells. We expressed V5-tagged NEDD8 in eukaryotic cells and captured 
neddylated conjugates on anti-V5-conjugated sepharose beads. Those beads were incubated in 
vitro with purified GST-BPLF1-N, resulting in hydrolysis of cellular NEDD8 conjugates. The 
same experiment was repeated with the difference, that Flag-BPLF1 was co-expressed in the 
V5-NEDD8 expressing eukaryotic cells. After lysing the cells and detecting the V5-NEDD8 
conjugates in a Western blot, we observed that BPLF1-N was able to hydrolyse the 
neddylated cellular conjugates. Thus, BPLF1-N appears to be a true deneddylase.  
After this indication we were wondering which cellular neddylated substrates are targeted by 
BPLF1-N. The best characterized neddylated cellular proteins are the cullin family, which 
comprise in human six members: Cul-1,-2,-3,-4a,-4b,-5. The C-terminal neddylation of 
Cullins assembled in cullin RING ligases (CRLs) was shown to enable a sufficient 
polyubiquitination of the particular CRL substrate protein (13, 14). In our studies we could 
show, that BPLF1-N was able to deneddylate Cul1 and Cul4a. We co-expressed in eukaryotic 
cells Flag-BPLF1-N with V5-NEDD8 and Myc tagged Cul1 and Cul4a, which are two 
representative members of the cullin family. After lysing the cells and running their lysate on 
a SDS-PAGE, we were able to detect BPLF1-N´s ability to hydrolyze V5-NEDD8 conjugated 
Cul1 and Cul4a.  
After showing this effect we wanted to investigate, if the enzyme also binds to those two 
cullins. We transfected eukaryotic cells with Flag-BPLF1-N and Myc-Cul1 or Myc-Cul4a and 
performed co-immunoprecipitations (Co-IPs). Cell lysates were separated and the Co-IPs 
were conducted in both ways, using the Flag- and Myc- antibody. Both cullins were shown to 
bind to BPLF1-N in both Co-IP´s (Flag- and Myc- antibody).  
After showing this interaction for overexpressed Cul1 and Cul4a, we repeated this Co-IP 
experiment performed with endogenously expressed Cul4a. We transfected eukaryotic cells 
with Flag-BPLF1-N and separated again the cell lysates, for Co-IP experiments in both ways, 
with an anti-Cul4a and an anti-Flag antibody. Endogenous Cul4a was able to bind Flag-
BPLF1-N, detected in the anti-Cul4a and anti-Flag Co-IP.  
Neddylation of cullins integrated in CRLs enables the E3-ligase complex to polyubiquitinate 
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its specific substrate, which leads to its proteasomal degradation (13). We were wondering, if 
we could stabilize known CRL substrates by overexpressing BPLF-1-N. By knowing that 
BPLF1 is a nuclear protein expressed in the early phase of the productive virus cycle, we 
assumed an involvement of the protein in DNA replication. Several CRL regulated substrates 
are involved in cell cycle control, like the licensing factor CDT1 and the tumor suppressor 
p21 and p27 (120, 121). All those proteins are targeted by Cul1 and/or Cul4 based CRLs 
(119). Expression of those CRL substrates together with BPLF1-N lead to their stabilisation 
detected via Western blot. The accumulation of those cell cycle regulators was reversed in a 
dose dependent manner by overexpression of V5-NEDD8, whereas a mutant V5-NEDD8-VV, 
lacking the C-terminal Gly residue required for conjugation, and HA-ubiquitin had minor or 
no effects.  
As described in earlier chapters, viral modulation of CRLs is a common mechanism to control 
pathways essential for the virus life cycle, like viral replication or hiding from the immune 
surveillance. Several DNA viruses, like HPV (75), Adenovirus (76), SV40 (79) and now also 
due to our studies EBV, have been described to manipulate CRLs to insure their undisturbed 
genome replication.  
After overexpression of BPLF1-N in various eukaryotic cell types it could be shown, that the 
enzyme localises predominately to the nucleus, detected via immunofluorescence. The effect 
of this nuclear accumulation of BPLF1-N was an increased size of the nucleus and on 
prolonged expression, extensive cell death. Those detected effects were not due its 
overexpression but due its catalytic activity, because a catalytic inactive mutant, BPLF1-N 
C61A missed to establish this phenotype. 
To investigate the cause of the nuclear enlargement, BPLF1-N transfected cells were stained 
with propidium iodide, a fluorescent agent, which binds to DNA. After this treatment the cell 
cycle profile and DNA content was assessed. Taken together the compiled results of those 
experiments indicated a deregulation of the S-phase and an ongoing re-replication of cellular 
DNA without mitosis (endoreduplication). Almost all BPLF1-N expressing cells died within 
4-5 days. This phenotype was reversed in a dose-dependent manner by overexpression of 
NEDD8 but not by overexpression of ubiquitin. This result suggests that BPLF1-N´s 
deneddylase activity rather then its DUB activity seems to be responsible for this here 
described  phenotype. Further BPLF1-N overexpression experiments in different eukaryotic 
cell lines elucidated the stabilisation of several CRL substrates or activation of certain 
regulator proteins, essential for DNA synthesis and cell cycle progressing. The composition of 
those activated or stabilised proteins favours the earlier described S-phase like 
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environment and endoreduplication in BPLF1-N expressing cells (see for details publication 
II). Among those stabilised proteins was the DNA licensing factor CDT1 (chromatin licensing 
and DNA replication factor 1). CDT1 functions as a regulatory protein of the pre-RC (pre-
replication complex), which is essential for the initiation of DNA replication. The pre-RC 
binds to the oriP (origin of replication) and “licenses” the initiation of replication during the 
S-phase. Cdt1 is tightly regulated through ubiquitin-dependent proteolysis facilitated by Cul1 
and Cul4 based CRLs (122). The involvement of the cellular DNA replication machinery in 
replication of the viral genome is poorly understood for the HHV-family.  
To elucidate whether the detected S-phase like environment and endoreduplication in BPLF1-
N expressing cells has an impact of viral replication we used the Akata-Bx1 cell line. This B-
cell lymphoma cell line carries a recombinant EBV genome within, which can be induced to 
start its lytic cycle by crosslinking of cell surface immunoglobulins. Entrance into the viral 
replication state can be visualised by the expression of a viral early protein substituted with 
GFP (green fluorescent protein). EBV replication in those cells caused the same phenotype as 
in BPLF1-N overexpressed cell lines, an S-phase like environment and endoreduplication, 
detected via cell cycle diagram assays.  
The same milieu of activated or CRL stabilised proteins essential for DNA synthesis and cell 
cycle progressing was detected in those EBV reactivated cells as in BPLF1-N expressing 
cells. Among them also the stabilised Cul1 and Cul4 based CRL target CDT1. Upon silencing 
BPLF1 expression in those induced Akata cells via shRNA (short hairpin RNA) against 
BPLF1 mRNA, the normal cell cycle diagram could be reconstituted. After overexpression of 
CDT1 in those BPLF1 knock downed cells, the BPLF1-N detected S-phase like phenotype 
could be reconstituted to a certain extend. This result demonstrates the big impact of the 
BPLF1-N stabilized CRL substrate CDT1. It also indicates the essential involvement of 
probably other stabilized CRL substrates to reconstitute the BPLF1-N overexpression 
phenotype.  
In order to investigate the impact of BPLF1 expression towards viral genome replication, we 
assayed the viral DNA contend in BPLF1 knock down induced Akata cells via RTq-PCR (real 
time quantitative-PCR). The knock down of BPLF1 resulted in an almost complete inhibition 
of virus DNA replication. Thereafter, we also wanted to investigate the impact of  
overexpressed CDT1 in BPLF1 knock downed, induced Akata cells. Overexpression of CDT1 
let to reactivation of viral replication to an almost full degree.  
To summaries, this data demonstrates that stabilisation of CDT1 is critical for the introduction 
of an S-phase-like cellular environment, and the driving factor for viral replication. 
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To investigate whether BPLF1-N´s deneddylase activity and caused induction of cellular 
DNA re-replication are conserved among the HHV-family, we tested the BPLF1 homologues 
UL36 of HSV and M48 of MCMV. GST fusions of the N-termini of UL36 and M48 cleaved 
the Ub-GFP and NEDD8-GFP reporter constructs with comparable efficiency in the above 
explained bacterial screening assay. Also Flag tagged UL36-N and M48-N reacted with the 
Ub-VS and NEDD8-VS suicidal probes as described earlier for Flag-BPLF1-N. 
Overexpression of Flag-UL36-N and Flag-M48-N also introduced an S-phase cellular 
environment and endoreduplication, as seen after Flag-BPLF1-N expression. Taken together, 
those results suggest that the function of BPLF1 is conserved among members of the HHV-
family.    
 
 
3.3  Publication III  
 
“AmotL2 links E-cadherin to contractile actin filaments and controls cell topology” 
 
The general aim of this work was to elucidate the function of AmotL2 p100 in epithelial cells. 
In this study, we describe that the longer AmotL2 isoform, AmotL2 p100, localizes to the 
adherens junctions of polarized epithelial cells and controls cell geometry and topology.  
We stably knocked down AmotL2 in MDCK and Caco-2 epithelial cells as in HaCaT 
keratinocytes by using shRNA carrying lentiviruses targeting AmotL2. After polarizing those 
AmotL2 shRNA cells we detected a loss of actin filaments that run perpendicular to the cell-
cell junctions. This loss of actin filaments destabilized the cellular architecture so 
dramatically, that cells were not able to maintain their typical cuboidal architecture. Instead 
cells collapsed and grew flat on their substrate leading to a ~6-fold increase of cellular surface 
area. This effect was due to the depletion of AmotL2 level as overexpression of human 
AmotL2 p100 in AmotL2 shRNA MDCK cells rescued normal cell surface area.  
Confluent grown polarized epithelial cells predominately adopt a hexagonal or pentagonal 
cell shape which is lost in AmotL2 shRNA cells. After polarizing AmotL2 depleted MDCK 
and Caco-2 cells their cellular shape was changed which resulted in cells bordering 
predominately to only four other neighbors. To confirm that the loss of contractile actin fibers 
was responsible for the seen effect we treated cells with the actin contractility inhibitor 
blebbistatin which affected epithelial cell geometry similar to the phenotype observed after 
AmotL2 depletion. 
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MDCK and Caco-2 cells form cyst-like structures when grown in soft matrix in vitro. Cyst 
formation was almost completely abrogated in AmotL2 shRNA cysts, which grew as clumps 
of cells with no distinguishable apical or basal compartments. The loss of the ability to form 
cysts may result from the lost capacity to establish normal epithelial cellular geometry. 
However, AmotL2 depletion in MDCK cells did not affect cell polarity, as detected by 
analyzing polarity markers as E-cadherin, β-catenin, Ezrin and podocalyxin. 
After detecting the loss of actin fibers causing alterations of cell geometry in different 
AmotL2 shRNA epithelial cells in vitro we were able to detect the same phenotype in 
AmotL2 knock out zebrafish embryos in vivo. We targeted the translation initiation site of 
AmotL2 using an anti-sense morpholino (MO) approach. Skin keratinocytes of AmotL2 MO 
zebrafish embryos showed an almost complete removal of cytoplasmic actin filaments. The 
cell surface area was doubled and the cell shapes shifted from predominately hexagonal 
towards preferential pentagonal shaped cells in AmotL2 MO skin keratinocytes. 
Co-immunoprecipitation strategies revealed that AmotL2 p100 binds to E-cadherin, MAGI1 
and actin. By mutating the first PY-motif of AmotL2, (precisely the LPTY-motif) we were 
able to disrupt the binding from AmotL2 to MAGI1 and actin. The binding towards E-
cadherin still needs to be elucidated. 
As we detected a loss of contractile actin filaments that run perpendicular to the cell-cell 
junctions we addressed the question if AmotL2 depletion would render epithelial sheet 
topology. AmotL2 shRNA keratinocytes were grown on flexible silicon matrices to 
confluency and in following stretched. AmotL2 shRNA cells broke at the sites of junctions 
due lack of supporting actin fibers whereat Ctrl shRNA could withstand the mechanical stress 
and keep attached to each other. 
The Hippo pathway is involved in organ size control by regulating cell proliferation, 
differentiation and apoptosis. The only downstream targets so far described are the 
transcriptional co-activators YAP and TAZ (Chan, Lim et al. 2013). By comparing AmotL2 
and YAP/TAZ activated gene levels in various tissues of various patient samples 
(GeneSapiens database) we found a clear correlation between YAP target genes and AmotL2 
expression across tissues.  
To analyze whether AmotL2 knockdown affected proliferation rates and contact inhibition we 
conducted cell-doubling assays. Analysis of the resulting growth curves showed that AmotL2 
shRNA cells had a slower growth rate and reached the stage of contact inhibition at a lower 
density than the Ctrl shRNA cells.  
Upon cell-cell contact YAP1 was described to re-localize to the cytoplasm explaining why 
47 
 
 
 
 
cells stop proliferating upon cell-cell contact (von Gise, Lin et al. 2012). By investigating 
YAP1 subcellular localization in response to increased cell density we could show that 
AmotL2 shRNA cells localize YAP1 earlier to the cytoplasm than the Ctrl shRNA cells. This 
effect was due to the increased cell size and thereby premature cell-cell contact inhibition in 
AmotL2 shRNA cells. These data were consistent with our findings in zebrafish where the 
skin of AmotL2 morphants exhibited a lower cellular density than the control morphants. 
We concluded that AmotL2 is a critical component in the adhesion junctions that controls 
intracellular contractility as well as relaying forces between cells. 
 
 
4.1  FURTHER PERSPECTIVES - EPSTEIN-BARR VIRUS ENCODED DECONJUGASES   
 
In previous experiments we could show, that BPLF1-N was able to bind to Cul1 and Cul4a. In 
order to address the question, if BPLF1-N was able to bind to the whole cullin family, we 
overexpressed all Myc-tagged cullins (Cul-1,-2,-3,-4a,-4b,-5) together with Flag-BPLF1-N in 
eukaryotic cells. In following we performed Co-IP experiments with Flag- and Myc- 
antibodies and were able to Co-IP Flag-BPLF1 with all Myc-cullins and also all Myc-cullins 
with Flag-BPLF1. These results indicate that CRLs comprised of the entire cullin family may 
be target of BPLF1-N.  
We were also interested to investigate on which cullin domain BPLF1-N binding occurs and 
if the binding is direct or if cellular adaptors are involved. To address this question we 
generated different GST tagged Cul4a domains. In following pull-down assays with 
eukaryotic cell lysates containing overexpressed Flag-BPLF1-N, we could identify its site of 
interaction towards the cullin C-terminus, closely located to the neddylation site. In order to 
investigate, if cellular adaptors are involved in this binding, the experiment was repeated with 
bacterial expressed and purified His-BPLF1-N. Also this attempt resulted in binding of 
BPLF1-N to the same C-terminal located Cul4a domain, showing that this interaction is direct 
and no cellular adaptors are involved.  
In order to elucidate the BPLF1-N residues involved in binding towards cullins, in silico 
sequence alignments among all human virus homologues of BPLF1_N were conducted. The 
alignment result revealed a conserved -helical structure located on the enzymes surface. A 
high degree on conservation was detected on two charged residues Asp86 and Asp90 pointing 
outwards of this -helix. After mutating those two residues into opposite charged residues 
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Asp86Arg and Asp90Arg the interaction of Flag-BPLF1_D86R_D90R towards Myc-Cul1 
and Myc-Cul4a could be reduced to 90%, detected via Co-IP experiments. To insure that 
this degrease in binding was not due possible structural changes caused by the mutation, the 
conserved - helical structure containing Asp86 and Asp90 were cloned into a bacterial His-
expression vector. In following the same mutations D86R_D90R were applied on this 
BPLF1-N helical fragment and pull down assays were conducted with GST-Cul4a. The result 
was showing again a 90% reduction in binding compared to the wild type BPLF1-N helical 
fragment. The outcome of those binding experiments strongly suggests that the two conserved 
residues Asp86 and Asp90 located within the conserved - helical structure are the essential 
residues involved in the interaction towards Cul1 and Cul4a and possibly to all cullins.  
 
 
 
4.2  FURTHER PERSPECTIVES - AMOTL2 IN CONTROL OF CELL TOPOLOGY 
 
In the third report of this thesis, we have identified a novel link between cell contacts and the 
cytoskeleton. The connection of E-cadherin to the actin filaments have been a point of great 
controversy (Drees, Pokutta et al. 2005). Our data shed light on this aspect as it identifies 
AmotL2 as a specific linker between E-cadherin and the cytoskeleton. However, a number of 
questions remain. For example, the exact composition of this complex is unclear. Future 
experiments using deletion constructs will provide evidence about which exact domains of 
AmotL2 mediate binding to E-cadherin and whether these are direct or indirect interactions.  
Another issue is how the ternary complex of AmotL2 and E-cadherin specifically orchestrates 
the development of actin filaments that run perpendicular to the cell membrane. The physical 
coupling of MAGI1 to AmotL2 is essential for the binding to actin. MAGI1 has been shown 
to bind GTPase exchange factor PDZ-GEF1 which in its turn activates RAP1 (a small GTPase 
known to regulate the actin cytoskeleton) (Sakurai, Fukuhara et al. 2006). It is therefore 
conceivable that the homotypic interaction of E-cadherin leads to the activation of RAP1 in an 
AmotL2 dependent manner and thus regulates actin fiber formation. Future experiments will 
address whether AmotL2 is required for RAP1 activity during cell contact formation. 
We present evidence that AmotL2 associates to actin filaments, which mechanically connect 
cells with each other and which are essential for maintaining epithelial geometry and 
topology. It is tempting to speculate that AmotL2 is part of a mechanotransduction complex 
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that can relay signals over multiple cell layers in epithelial sheets. Future experiments will 
perhaps provide evidence on whether mechanical and biochemical signals can be transduced 
via AmotL2. One possible effector is clearly YAP1, however, our experiments indicate that 
AmotL2 indirectly controls YAP1 cellular localization by regulating cell shape.  
Is AmotL2 essential for normal organogenesis? Parallel studies in the lab by Hultin, Zheng et 
al. show that AmotL2 is required for the expansion of the dorsal aorta. This was shown in 
zebrafish and in mouse. Using conditional AmotL2 KO mice it will be possible to address 
whether AmotL2 is required for normal skin development and function. This should be also 
tested in models of wound healing and tumor development. Taken together, the data presented 
in paper 3 will perhaps provide the grounds for further studies on how epithelial cells connect 
mechanically and how force may be translated to biochemical signals. 
We could show in our experiments that AmotL2 depleted keratinocytes (HaCaT) were able to 
undergo cell-cell contact inhibition leading to a termination of proliferation. AmotL2 shRNA 
cells undergo earlier inhibition than the Ctrl shRNA cells due to their increased cell size 
leading to lower cell counts per defined cell area. As a readout of proliferation termination we 
used the cytoplasmic localization of the transcriptional co-activator YAP1 towards the 
cytosol. The relocalization of YAP1 from the nucleus to the cytoplasm in confluent cells has 
been suggested to explain why cells stop proliferating upon cell-cell contact (von Gise, Lin et 
al. 2012). We would like to confirm the end of proliferation via the more established BrdU 
cell proliferation assay. BrdU is a chemical dye, which substitutes for thymidine in newly 
synthesized DNA. A later used BrdU antibody visualizes the compound, detecting cells which 
are still proliferating (Waldman, Dolbeare et al. 1988). We also want to confirm our data by 
reproducing the conducted proliferation assays with other epithelial cell lines, like AmotL2 
shRNA MDCK and Caco2 cells. 
We could detect via co-immunoprecipitation strategies, that AmotL2 p100 binds to the 
adherens junctions components E-cadherin, MAGI1 and actin. We pinpointed the site of 
interaction from MAGI1 and actin towards the N-terminal located LPTY-motif of AmotL2 
p100 by substituting the tyrosine to alanine on that conserved binding site. To elucidate the 
site of interaction towards E-cadherin, we want to repeat our co-immunoprecipitation 
experiments by overexpressing truncated AmotL2 p100 fragments covering the whole protein 
length. We detected a vanishing of contractile actin fibers which run perpendicular to cell-cell 
junctions causing alterations of cell geometry in different AmotL2 shRNA epithelial cells in 
vitro as well as in AmotL2 KO zebrafish embryos in vivo. We generated AmotL2 KO mice 
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and want to evaluate cell geometry in mice skin to verify our data.  
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